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ABSTRACT 
Glutamate, the main excitatory neurotransmitter in the mammalian brain, plays an 
important role during brain development and physiological functioning throughout life by 
activation of ionotropic NMDA receptors. However, glutamate is also involved in a 
pathological process called excitotoxicity, whereby elevated release of glutamate over-
activates synaptic and extrasynaptic NMDA receptors leading to rapid neuronal cell 
death. This excitotoxic mechanism is largely responsible for cell death in many 
neuropathological diseases, including stroke.  
Recent literature has suggested an interaction between NMDA receptors and 
nicotinergic signaling via the α7 nicotinic acetylcholine receptors (α7 nAChRs). The 
potential role of α7 nAChRs in mediating glutamate toxicity, however, is somewhat 
controversial with reports of α7 nAChRs being both neuroprotective and neurotoxic in 
certain systems. The purpose of this thesis was to investigate the effects of co-activation 
of α7 nAChRs on NMDA-mediated excitotoxicity in vitro using organotypic 
hippocampal slice cultures (OHSCs).  
In order to compare the effects of different treatments on cell viability of OHSCs, a 
standardized method to objectively quantify cell death using the fluorescent dye 
propidium iodide (PI), a common marker for membrane integrity and cell injury, was 
developed. Hippocampal subfields were separated sing simple landmarks and PI intensity 
was quantified by densitometry in 10 template-oriented counting fields.   
OHSCs were prepared from postnatal day 5-6 Sprague-Dawley rats according to the 
membrane interface method and maintained for 13 days. After confirming viability using 
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PI, slices were exposed for 4 hours to varying concentrations of NMDA and PI uptake 
was quantified after 24 hours in fresh media. Exposure to increasing concentrations of 
NMDA resulted in a dose-dependent increase in PI fluorescence intensity, an effect found 
in all hippocampal subfields analysed (dentate gyrus, CA1, and CA3). Furthermore, 
comparison of PI uptake in the three subfields showed a region-specific vulnerability of 
the hippocampus to NMDA-mediated cytotoxicity, with the CA1 region being the most 
sensitive.  
To characterize the contribution of α7 nAChRs in NMDA-mediated excitotoxicity, 
OHSCs were exposed to a combination of NMDA and the specific α7 nAChR agonist 
choline and the allosteric potentiating ligand galantamine. Results revealed that co-
activation of α7 nAChRs does not significantly alter NMDA-induced excitotoxic cell 
damage in OHSCs as measured by PI uptake. Activation of α7 nAChRs in the absence of 
NMDA, however, significantly increased cell death in some hippocampal regions, 
suggesting a possible neurotoxic effect that would require further investigation. 
 
  
vi 
 
ACKNOWLEDGMENTS 
I would like to thank the members of my supervisory committee, Dr. Collins Kamunde, 
Dr. Sunny Hartwig, Dr. Tracy Doucette and Dr. Daphne Gill, for their many comments 
and helpful suggestions.  
I would like to extend special thanks to my supervisor, Dr. Andy Tasker, whose 
expertise, guidance, and encouragement made this work possible. Thank you for all of 
your help throughout the years. 
I also thank Debra MacDonald for the technical training, assistance and support. Thank 
you to all of the current and past students in the lab for their assistance with this project in 
and outside of the lab.  
I would like to acknowledge and thank the Department of Biomedical Sciences, 
Innovation PEI Graduate Student Award, and the Dr. Regis Duffy Graduate Science 
Scholarship for personal funding as well as AVC Internal Research Fund and the 
Lundbeckfonden for providing funding for the research.  
Finally, thank you to my family and friends for their support and encouragement over the 
years.  
  
vii 
 
TABLE OF CONTENTS 
Chapter 1: General introduction 1 
1.1 Stroke 2 
1.2  The pathology of ischemia 2 
1.3 Glutamate and glutamate receptors in the brain 7 
1.3.1 The NMDA receptor 9 
1.4  NMDA Receptor-mediated neuronal survival and ischemic injury 11 
1.5 Acetylcholine and acetylcholine receptors 19 
1.5.1 Nicotinic acetylcholine receptors 20 
1.5.2 The α7 nicotinic acetylcholine receptor 22 
1.6 Interaction between NMDA receptors and α7 nicotinic receptors 25 
1.7 Organotypic hippocampal slice cultures 27 
1.7.1 Hippocampus 28 
1.7.2 Methodological aspects for the use of organotypic hippocampal slice cultures 30 
1.7.3 Rationale to use organotypic hippocampal slice cultures as an in vitro model of 
excitotoxicity 33 
1.8 Experimental rationale, hypothesis and study objectives 34 
Chapter 2: Development of a method to objectively quantify cell death in organotypic 
hippocampal slice cultures using propidium iodide 35 
Summary 36 
2.1 Introduction 37 
2.2 Methods 41 
2.2.1 Experimental animals 41 
2.2.2 Preparation and maintenance of organotypic hippocampal slice cultures 42 
2.2.3 Assessing viability using propidium iodide 43 
2.2.4 Drug application 43 
2.2.5 Image analysis and quantification of PI fluorescence 44 
2.2.6 Data analysis 46 
2.3 Results 47 
2.3.1 Dose dependent excitotoxic effects of NMDA 47 
2.3.2 Differential susceptibility of hippocampal subfields to NMDA 49 
2.4 Discussion 53 
viii 
 
Chapter 3: Evaluation of interaction of NMDA receptors and α7 nicotinic acetylcholine 
receptors 62 
Summary 63 
3.1 Introduction 64 
3.2 Methods 70 
3.2.1 Experimental animals 70 
3.2.2 Preparation and maintenance of organotypic hippocampal slice cultures 71 
3.2.3 Assessing viability in organotypic slice cultures 71 
3.2.4 Drug application 72 
3.2.5 Image analysis and quantification of PI fluorescence 73 
3.2.6 Data analysis 74 
3.3 Results 74 
3.3.1 Saline control groups 75 
3.3.2 Low dose of NMDA (10 µM) in combination with α7 nicotinic receptor agonist 78 
3.3.3 High dose of NMDA (50 µM) in combination with α7 nicotinic receptor agonist 81 
3.4 Discussion 84 
Chapter 4: Overall conclusions and future directions 93 
4.1 Conclusions 94 
4.2 Future directions 96 
Appendix A: Development of the quantification protocol - Effects of culture media 98 
Appendix B: Validation of the cell death quantification method in organotypic 
hippocampal slice cultures 103 
Appendix C: Effect of depolarization using domoic acid on NMDA receptor-mediated 
excitotoxicity in organotypic hippocampal slice cultures 111 
Appendix D: Immunohistochemical staining with neuronal and astrocytic markers 123 
References 127 
  
ix 
 
LIST OF FIGURES 
Figure 1-1: Overview of the pathological events in the ischemic cascade 3 
Figure 1-2: General overview of pro-survival and pro-death signalling pathways associated with 
NMDA receptors 17 
Figure 2-1: Standard template for quantification of propidium iodide 45 
Figure 2-2: Dose-response relationship between NMDA and propidium iodide uptake 48 
Figure 2-3: Dose–response relationship between NMDA and propidium iodide uptake in 
hippocampal subregions 50 
Figure 3-1: Cellular propidium iodide uptake measured in the three hippocampal regions 76 
Figure 3-2: Effects of co-activation of α7 nicotinic acetylcholine receptors on 10 μM NMDA-
induced excitotoxicity 80 
Figure 3-3: Effects of co-activation of α7 nicotinic acetylcholine receptors on 50 μM NMDA-
induced excitotoxicity 83 
Figure A-1: Standard template to facilitate quantification of propidium iodide 100 
Figure B-1: Hippocampal slice culture double-labelled with DAPI and Fluoro-Jade C 108 
Figure B-2: Fluoro-Jade C uptake in organotypic hippocampal slice cultures 109 
Figure C-1: Cell damage in the dentate gyrus after exposure to domoic acid 114 
Figure C-2: Cell damage in CA1 after exposure to domoic acid 118 
Figure C-3: Cell damage in CA3 after exposure to domoic acid 120 
Figure D-1: Double staining for NeuN and GFAP in organotypic hippocampal slice cultures 126 
  
x 
 
LIST OF TABLES 
Table 1-1: Overview of theories to explain opposing roles of NMDA receptor activation 14 
Table 2-1: Fluorescence microscope settings for propidium iodide imaging 43 
Table 2-2: Propidium iodide uptake in the dentate gyrus, CA3 and CA1 hippocampal regions in 
organotypic slice cultures treated with increasing concentrations of NMDA 51 
Table 3-1: Summary of drug treatments 73 
Table 3-2: PI uptake after exposure to saline in combination with α7 nicotinic receptor agonists 77 
Table 3-3: PI uptake after exposure to a low dose of NMDA in combination with α7 nicotinic 
receptor agonists 81 
Table 3-4: PI uptake after exposure to a high dose of NMDA in combination with α7 nicotinic 
receptor agonists 84 
Table B-1: Laser confocal microscope settings for Fluoro-Jade C quantification. 106 
Table B-2: Fluoro-Jade C uptake after exposure to increasing concentrations of NMDA 107 
Table C-1: Propidium iodide uptake in organotypic slice cultures treated with domoic acid 116 
 
  
xi 
 
ABBREVIATIONS 
Aβ  β-amyloid 
ACh  acetylcholine 
AChE  acetylcholinesterase 
AD  Alzheimer’s disease 
Akt  protein kinase B 
AMPA  a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
ANOVA  analysis of variance 
APL  allosteric potentiating ligand 
ATP  adenosine triphosphate 
BBB  blood brain barrier 
BCL-2  B-cell lymphoma 2 
BDNF  brain-derived neurotrophic factor 
CA  cornu ammonis 
CaMKIV   calmodulin kinase IV 
CRE  cyclic adenosine monophosphate response element 
CREB  CRE binding protein 
CNS  central nervous system 
DAPI  4’, 6-diamidino-2-phenylindole 
DG  dentate gyrus 
DIV  day in vitro 
DMXB-A  3-[(2,4-dimethoxy) benzylidene]anabaseine  
DNA  deoxyribonucleic acid 
DOM  domoic acid 
ERK  extracellular signal-regulated kinase 
xii 
 
FJC  Fluoro-Jade C 
GABA  gamma-aminobutyric acid 
GFAP  glial fibrillary acidic protein 
GLAST  glutamate aspartate transporter  
GLT-1  glutamate transporter 1 
Glu  glutamate 
GluR  glutamate receptor 
GPCR  G-protein coupled receptor 
HEK-293  human embryonic kidney-293 cell line 
iGluR  ionotropic glutamate receptor 
JAK2  januse kinase 2 
LDH  lactate dehydrogenase 
LTP  long-term potentiation 
MEM  minimum essential media 
mGluR  metabotropic glutamate receptor 
nAChR  nicotinic acetylcholine receptor 
NMDA  N-methyl-D-aspartate 
NMDAR   NMDA receptor 
NO  nitric oxide 
NOS  nitric oxide synthase 
OHSC  organotypic hippocampal slice culture 
PBS  phosphate buffered saline 
PI   propidium iodide 
PI3K  phosphatidylinositol 3-kinase 
PND  postnatal day 
xiii 
 
PSD95  postsynaptic density protein-95 
SEM  standard error of the mean 
WST-1  water soluble tetrazolium-1 
 
1 
 
 
 
 
 
 
CHAPTER 1:  
GENERAL INTRODUCTION  
2 
 
1.1 STROKE 
Stroke is one of the main causes of death and disability, affecting approximately 
800,000 people each year in the United States alone (Mozaffarian et al, 2016). 
Furthermore, the majority of survivors are left with disabilities, including motor 
disabilities as well as cognitive deficits and depressive symptoms (Adamson et al, 2004; 
Go et al, 2013). The impact of stroke extends far beyond the individual into the wider 
public and economy: direct and indirect costs associated with hospitalization and 
rehabilitation amount to approximately $33 billion in the United States alone (in 2011 to 
2012) (Mozaffarian et al, 2016). 
Stroke is a diverse neurological condition broadly categorized as either ischemic or 
hemorrhagic. Ischemic strokes result from occlusion of a cerebral artery by a thrombus or 
embolus, causing a lack of oxygen and glucose, which eventually leads to cell injury or 
cell death within the affected brain region. In contrast, rupture of an artery within the 
brain is the underlying cause of hemorrhagic strokes. About 85-90% of all strokes 
diagnosed are ischemic (Go et al, 2013). Because of its high prevalence, the work in this 
thesis will focus on ischemic strokes. 
 
1.2 THE PATHOLOGY OF ISCHEMIA 
When blood supply to a brain region is interrupted, a complex series of cellular 
events is triggered that leads to the degeneration of brain tissue. These pathological 
events are often referred to as an ischemic cascade (Lee et al, 2000) (see Figure 1-1 for 
an overview). While the initial insult can rapidly lead to brain damage in areas that 
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Figure 1-1: Overview of the pathological events in the ischemic cascade. Following an ischemic insult, loss of oxygen and glucose cause energy 
loss and downstream effects such as excitotoxicity, free radical production and blood-brain barrier disruption, that can result in apoptosis or necrosis. 
Figure created by Denise Happ, based on information from several publications cited in section 1.2.  
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are severely affected, ischemic brain injury to less affected cells may occur hours or even 
days later (Durukan and Tatlisumak, 2007). The fundamental mechanisms of the 
ischemic cascade have been identified, but the exact sequence of events is difficult to 
determine as many events of the ischemic cascade demonstrate overlapping features and 
are indistinguishably connected (Neumar, 2000).  
Ischemic core and penumbra 
Depending on the severity and length of the reduction in blood flow, the affected brain 
tissue can be divided into two regions: the ischemic core and the surrounding ischemic 
penumbra. The core of the infarct is characterized by complete lack of blood flow 
resulting in irreversible cell death within minutes. In contrast, the ischemic penumbra 
experiences less severe ischemic damage due to the presence of collateral blood vessels 
that continue to supply the area. Although the moderate reduction in blood flow can 
cause further damage, cells in the penumbra can maintain structural integrity, membrane 
potential and ion gradients temporarily. Thus, the disruption of cellular homeostasis is 
less severe and leads to the development of a region with reversible damage. The 
penumbra can be salvaged provided blood flow is restored in time, but the tissue can also 
progress to irreversible damage (Hertz, 2008). Following stroke, neuronal cell death can 
be caused by necrotic or apoptotic mechanisms, depending on the intensity of the 
stimulus. Acute, permanent vascular occlusion results in necrotic cell deaths, which 
predominantly characterizes neuronal cells within the ischemic core. In contrast, cells 
undergo a delayed type of cell death called apoptosis subsequent to milder injury, 
particularly within the penumbra (Bonfoco et al, 1995; Neumar, 2000).  
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Energy depletion and failure of ion pumps 
The brain is dependent on a steady supply of oxygen and glucose from the blood to 
produce adenosine triphosphate (ATP) and thereby maintain energy-dependent 
physiological function. As a result of diminished blood flow, depletion of oxygen and 
glucose causes a subsequent decrease in ATP that leads to the dysfunction of ATP- 
dependent ion pumps that maintain the neuronal resting potential, such as Na
+
/K
+
-
ATPase and Ca
2+
-ATPase, as well as the reversal of Na
+
/Ca
2+
 transporter. Failure of these 
ion pumps results in elevated concentrations of intracellular sodium, calcium and chloride 
as well as high extracellular levels of potassium, leading to the loss of neuronal 
membrane potential and depolarization of neurons and glial cells (Lipton, 1999).  
Due to this anoxic depolarization, excessive amounts of neurotransmitters, 
particularly glutamate (Glu), are released into the extracellular environment, promoting 
further advancement of injury cascades and initiating Glu-mediated excitotoxic cell death 
(Lee et al, 2000).  
Glutamate-mediated excitotoxicity 
Under physiological conditions, extracellular Glu is maintained at low levels by 
presynaptic and astrocytic reuptake mechanisms. Following ischemic stroke, these 
sequestering systems are impaired causing accumulation of Glu in the extracellular space 
(Takahashi et al, 1997).  The excessive levels of Glu over-activate various types of 
glutamate receptors (GluRs), especially the ionotropic N-methyl-D-aspartate (NMDA) 
receptor (NMDAR), which leads to an overflow of Ca
2+
 into the cell. Stimulation of 
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GluRs also promotes the influx of sodium and chloride, with water following passively, 
causing swelling in the neuronal cell body and dendrites (Lee et al, 2000).  
Calcium overload is generally thought to be a key factor in excitotoxicity-mediated 
cell death (Arundine and Tymianski, 2003; Doyle et al, 2008; Hazell, 2007; Szydlowska 
and Tymianski, 2010). In addition to calcium influx from the extracellular compartment, 
Ca
2+
 may also be released from intracellular stores, such as the endoplasmic reticulum 
(Paschen and Doutheil, 1999; Pisani et al, 2000) or mitochondria (Szydlowska and 
Tymianski, 2010; Webster, 2012).  An increase in Ca
2+
 concentrations can initiate the 
activation of several enzymes, including calpains and other proteases, lipases, 
phosphatases, nitric oxide (NO) synthase (NOS), and endonucleases (Szydlowska and 
Tymianski, 2010; Xing et al, 2012). The consequences of changed activity of these 
enzymes include overproduction of free radicals, lipid peroxidation, irreversible 
mitochondrial damage, and ultimately induction of necrotic and apoptotic cell death 
(Durukan and Tatlisumak, 2007).  
Mitochondrial damage 
Mitochondria play an important role in cellular energy production, physiological 
calcium homeostasis and generation of oxygen radicals (Norenberg and Rao, 2007). 
Upon excitotoxicity-mediated calcium inflow, mitochondria can take up Ca
2+
 in an effort 
to recover the intracellular concentration. However, mitochondrial calcium overload can 
cause the production of reactive oxygen species such as superoxide and reduced ATP 
synthesis. In addition, the mitochondria undergo a phenomenon called “mitochondrial 
permeability transition”, resulting from the formation and opening of a permeability 
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transition pore in the inner membrane of the mitochondria. The increased permeability of 
the mitochondrial membrane promotes mitochondrial swelling and the release of 
apoptotic mediators, such as cytochrome c and apoptosis inducing factor (Dirnagl, 2012; 
Norenberg and Rao, 2007; Starkov et al, 2004). 
Oxidative Stress 
During ischemic injury, endogenous defences against reactive oxygen species, such 
as glutathione and superoxide dismutase, may be impaired as a result of decreased energy 
production (Hazell, 2007). Damaging free radicals, including superoxide, hydroxyl 
radical, and NO, can be produced by mitochondria and NMDA receptor-mediated 
activation of NOS. Additionally, overproduction of free radicals can follow reperfusion, 
as the reoxygenation provides a substrate for numerous enzymatic oxidation reactions 
(Sugawara et al, 2004). Free radicals, such as NO and superoxide, can damage 
endothelial cells through activation of matrix metalloproteinases and thereby disrupt the 
blood brain barrier (BBB).  Increased BBB permeability contributes further to ischemic 
injury and cell death by allowing the influx of inflammatory cells and toxins (Chen et al, 
2011; Doyle et al, 2008). Additionally, elevated influx of Na
+
 and Cl
-
 due to altered BBB 
permeability can cause passive influx of water, leading to edema (Dirnagl et al, 1999; 
Gotoh et al, 1985). 
 
1.3 GLUTAMATE AND GLUTAMATE RECEPTORS IN THE BRAIN 
The amino acid Glu is the main excitatory neurotransmitter in the mammalian central 
nervous system (CNS). Due to the ubiquitous distribution of glutamatergic synapses, Glu 
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is critically involved in physiological functioning including brain development, plasticity, 
and memory processes (Meldrum, 2000). High concentrations of Glu, however, can have 
detrimental effects on neurons and cause neuronal cell death by excitotoxicity. It has been 
suggested that excitotoxicity is an extension of physiological function, and that excessive 
activation of GluRs results in neuronal damage (Sattler and Tymianski, 2001). This 
pathological process has been implicated in a variety of neuropathological diseases, 
including stroke and traumatic brain injury (Arundine and Tymianski, 2003; Kalia et al, 
2008), as well as in neurodegenerative diseases, such as Alzheimer’s disease (AD) 
(Miguel-Hidalgo et al, 2002), Parkinson’s disease (Armentero et al, 2006), and 
Huntington’s disease (Ferrante et al, 1993).  
The balance of glutamatergic activity is important for normal functioning of the 
brain. The extracellular Glu concentration is normally kept low by Na
+
-dependent Glu 
transporters, such as the glutamate aspartate transporter (GLAST) and glutamate 
transporter 1 (GLT-1) (Robinson and Jackson, 2016). GLAST and GLT-1 are 
preferentially expressed on astrocytes, providing this cell type with an enormous capacity 
for Glu uptake. Once inside the astrocytes, Glu can be oxidatively metabolized or 
transformed into glutamine, which is released and subsequently taken up by neurons to 
use as a Glu precursor (Schousboe and Waagepetersen, 2005).   
The excitatory responses of Glu are mediated by two receptor families: 
metabotropic glutamate receptors (mGluRs) and ionotropic glutamate receptors (iGluRs). 
Metabotropic glutamate receptors are ligand-gated G-protein coupled receptors (GPCRs) 
that can alter the activity of iGluRs and coupled channels via second messenger cascades 
(Boldyrev, 2000). The mGluR family consists of eight different receptor types, which can 
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be subdivided into groups 1-3 depending on receptor structure and physiological activity 
(Hermans and Challiss, 2001). Metabotropic GluRs are expressed by neurons and glia in 
the CNS and are typically located near the synaptic cleft, where they can modulate the 
effect of Glu on postsynaptic receptors and the release of Glu and other neurotransmitters 
(Julio-Pieper et al, 2011). 
The ionotropic receptor family is divided into NMDA, α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA), and 2-carboxy-3-carboxymethyl-4-
isopropenylpyrrolidine (kainate) receptor subfamilies, each of which are named after 
their prototypical agonists. All iGluRs are typically made up of four subunits that form 
the ion channel pore allowing cation influx upon Glu binding (Traynelis et al, 2010). 
Over the years, almost every type of GluR has been implicated in excitotoxic cell death, 
but NMDAR activation is thought to be the primary cause of Glu-mediated excitotoxicity 
due to its abundant expression and high calcium permeability (Mehta et al, 2013). 
1.3.1 The NMDA receptor 
NMDA receptors are heterotetramers that are formed by combination of the 
receptor subunits  NR1, NR2 and NR3. For the assembly of a functional NMDA receptor, 
two NR1 subunits appear to be obligatory and can be combined with either two NR2 
subunits or, less commonly, a combination of NR2 and NR3 subunits (Traynelis et al, 
2010). Through alternative splicing eight different NR1 isoforms can be generated. There 
are four different NR2 subunits (NR2A-D) encoded by four genes, with the NR2A and 
NR2B being the predominant NR2 subunits in the hippocampus. The NR3 family 
contains two members (NR3A-B) encoded by two genes (Paoletti, 2011). Consequently, 
a multitude of possible combinations of subunits are possible allowing for NMDA 
10 
 
receptor assemblies with distinct patterns of expression and functional properties (Paoletti 
and Neyton, 2007). This functional diversity is reflected in differences in channel 
conductance, gating properties, regional expression profiles, pharmacological properties 
and downstream signaling mechanisms. For example, NMDARs containing NR2A or 
NR2B subunits show a higher conductance and higher sensitivity to the Mg
2+
 block 
compared to receptors containing NR2C and NR2D subunits (Paoletti, 2011). 
NMDA receptors are generally expressed throughout the brain, but the expression 
of distinct subunits is differentially regulated depending on the developmental stage and 
brain area. Monyer et al (1994) showed that the NR1 subunit is expressed at high levels 
in the majority of neurons throughout development. Early in development expression of 
the NR2B subunit predominates, but then decreases over time, whereas NR2A is absent 
at first and increases with maturation in the hippocampus and cortex. Although evidence 
suggests this is a general trend, the expression of subunits may vary within different brain 
regions (Cull-Candy et al, 2001; Gladding and Raymond, 2011; Yamakura and Shimoji, 
1999). Additionally, there may also be variations in the NR2 subunit composition 
depending on the cellular location of the NMDA receptor (Cull-Candy et al, 2001). With 
regards to the subcellular location, NMDARs are typically found at postsynaptic sites, but 
presynaptic NMDARs have also been described (Corlew et al, 2008).  
Compared to other iGluRs, the classical NMDARs (i.e. NMDARs lacking NR3 
subunits) have several unique characteristics. First, the activation of NMDARs requires 
simultaneous binding of Glu and its co-agonist glycine. The NR2 subunit contains the 
binding site for Glu, whereas the glycine binding site can be found on the NR1 subunit 
(Kalia et al, 2008). Moreover, the receptor channel is blocked by extracellular Mg
2+
 at 
11 
 
resting potential. The Mg
2+
 block is removed by membrane depolarization resulting in a 
voltage-dependence. In addition to Na
+
 and K
+
, the NMDAR channel is also highly 
permeable to Ca
2+
 and displays slower activation and deactivation kinetics compared to 
AMPA and kainate receptors. Finally, the activity of the classical NMDAR can be 
modulated by extracellular compounds, which are usually small molecules or ions such 
as Zn
2+
 and H
+
  (Paoletti, 2011). 
 
1.4 NMDA RECEPTOR-MEDIATED NEURONAL SURVIVAL AND ISCHEMIC 
INJURY 
NMDA receptor signaling plays a dual role in the physiology and pathophysiology 
of the CNS. While physiological function of NMDARs mediated by Ca
2+
 entry is 
important during brain development and throughout life, intense or chronic activation of 
NMDARs under pathological conditions can lead to cell death via excitotoxic 
mechanisms. The term excitotoxicity was coined by Olney, who showed that this specific 
neurotoxic mechanism was not limited to retinal neurons (Olney, 1969). Subsequent 
experiments suggested the involvement of calcium as a key element of Glu-mediated 
toxicity (Choi, 1985; Simon et al, 1984) and NMDA receptors as the primary source of 
toxic Ca
2+
 entry (Rothman and Olney, 1987; Tymianski et al, 1993a).  
In the last 30 years, excitotoxicity linked to NMDA receptors has been implicated as 
the underlying cause in many neuropathological diseases due to acute excitotoxic insults 
during stroke (Margaill et al, 1996) or traumatic brain injury (Biegon et al, 2004; Faden 
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et al, 1989). In stroke specifically, Glu excitotoxicity mediated by NMDA receptors 
seems to be the main pathway to neuronal cell death (Zhou and Sheng, 2013). 
The mechanism of NMDAR-mediated excitotoxicity is thought to be linked to 
excessive Ca
2+
 entry. Because of its potentially devastating consequences, intracellular 
calcium levels are usually highly regulated via sequestration and extrusion, for example 
via the plasma membrane Na
+
/Ca
2+
 exchanger. Under ischemic conditions, however, 
these regulatory sodium-calcium-transporters may be dysfunctional, leading to the 
deregulation of calcium homeostasis (Bano et al, 2005) 
Antagonists of NMDARs have been shown to protect against excitotoxic cell death 
in ischemic models in vivo (Margaill et al, 1996; Yu et al, 2015) and in vitro (Garcia de 
Arriba et al, 2006), but many experimental NMDAR antagonists are ineffective or 
produce unacceptable side effects in clinical studies (Ikonomidou and Turski, 2002; 
Minnerup et al, 2012; Sacco et al, 2001). For this reason, research has since focused on 
the dual actions of NMDA receptors and specific downstream signaling pathways, as 
these receptors seem to be able to promote neuronal health as well as cause neuronal 
death (Hardingham et al, 2002; Liu et al, 2007; Papadia and Hardingham, 2007). Using 
this approach, a neuroprotective agent for stroke called NA-1 has shown promising 
results in several animal models (Cook et al, 2012; Sun et al, 2008) as well as in a phase 
2 clinical trial (Hill et al, 2012) and is currently undergoing phase III clinical trials. NA-1 
inhibits the interaction between NMDA receptors and the postsynaptic density protein-95 
(PSD95), dissociating the receptors from neurotoxic downstream signaling pathways 
without affecting necessary synaptic activity (Aarts et al, 2002). 
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Various theories to explain these seemingly contradictory actions of NMDARs have 
been brought forward, the most prominent being the degree of Ca
2+
 entry, the role of 
receptor location and the subunit composition (see Table 1-1 for an overview of the 
different theories). Early research identified the amount of calcium entering through 
NMDA receptors as a determining factor for the dual role of NMDARs. While excess 
NMDA receptor activity leads to neuronal death due to excessive Ca
2+
 influx, too little 
activation of NMDARs can also be detrimental. Therefore, moderate stimulation of 
NMDA receptors seems to be key for neuronal survival (Lipton and Nakanishi, 1999).   
More recent studies have offered an alternative theory that suggests different roles 
for synaptic versus extrasynaptic NMDARs. As mentioned above, NMDARs can be 
localized at synaptic, extrasynaptic, and perisynaptic sites. During early development of 
hippocampal neurons, extrasynaptic NMDARs make up the largest part of the NMDAR 
population. The ratio of extrasynaptic to synaptic NMDARs decreases over time, but a 
significant number of NMDARs stay at extrasynaptic locations throughout life (Cottrell 
et al, 2000; Petralia et al, 2010). Experiments conducted by Hardingham et al (2002) in 
hippocampal neurons revealed synaptic NMDARs are neuroprotective, whereas 
extrasynaptic NMDARs seem to be associated with cell death pathways. Moreover, the 
distinct receptor groups may be linked to different signaling pathways depending on their 
subcellular location (Hardingham et al, 2002; Ivanov et al, 2006), resulting in either cell 
survival or cell death. Therefore, excitotoxicity may not be the consequence of a general 
calcium overload, but rather calcium entry through a distinct subgroup of NMDARs may 
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Table 1-1: Overview of theories to explain opposing roles of NMDA receptor activation 
Theory Details References 
Calcium hypothesis  Excessive intracellular Ca
2+
 levels 
initiates cell death signaling 
mechanisms 
Choi, 1985, 1987 
Source specificity of Ca
2+
 Main determinant of Ca
2+
 toxicity is 
not the degree of Ca
2+
 loading, but 
the entry route 
Sattler et al, 1998; 
Tymianski et al, 1993 
NMDA receptor location Synaptic NMDA receptors promote 
neuronal survival, while 
extrasynaptic NMDARs mediate 
excitotoxicity  
Hardingham and Bading, 
2010 
NMDA receptor 
composition 
Differential roles for NR2A- and 
NR2B-containing NMDA receptors, 
with NR2A mediating neuronal 
survival and NR2B inducing 
excitotoxicity 
Liu et al, 2007 
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cause neuronal cell death (Hardingham and Bading, 2010). In contrast, work by Sattler et 
al (2000) in cortical cell cultures provided evidence that NMDA receptors located at 
synapses as well as outside of synapses have the ability to mediate excitotoxicity in vitro. 
The authors proposed that the mechanism of receptor stimulation controls the fate of the 
neurons, not their receptor location.  
Some literature suggests that the subunit composition of NMDARs, rather than 
subcellular receptor localization, confers the seemingly opposing effects of NMDAR 
activation. Special attention has been paid to NR2A and NR2B subunits, as they exhibit 
distinct properties. For example, NR2A-containing receptor channels exhibit a higher 
open probability than NR2B-containing receptors, whereas NR1/NR2B receptors 
contribute more to calcium influx than NR1/NR2A (Erreger et al, 2005). Additional 
differences in receptor characteristics include deactivation times (Vicini et al, 1998), 
varying affinity to Glu (Sanz-Clemente et al, 2013), and differential roles in long-term 
potentiation (LTP) (Massey et al, 2004). With regards to excitotoxicity, work by Liu et al 
(2007) provided evidence for the importance of subunit composition, irrespective of 
receptor localization. Using both in vitro and in vivo models, synaptic and extrasynaptic 
NR2A-containing NMDARs showed a neuroprotective effect, whereas activation of 
either synaptic or extrasynaptic NR2B-containing receptors resulted in excitotoxicity. For 
example, blockade of NR2B-containing receptors with a subunit specific antagonist 
prevented neuronal cell death following NMDA application in vitro, whereas inhibition 
of NR2A-containing receptors increased NMDA-induced cell death (Liu et al, 2007). The 
authors suggest that different NMDAR subunits may be connected to distinct 
downstream signaling mechanisms causing these opposing effects. 
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While the molecular basis for excitotoxicity has not yet been fully defined, it seems 
likely that several factors – receptor location (synaptic vs extrasynaptic), subunit 
composition (NR2A vs NR2B) as well as the amount of Ca
2+
 entering the cell – are 
involved in the excitotoxic effects of NMDAR over-activation (Stanika et al, 2010). 
However, it appears that neuronal survival mediated by NMDA receptors is generally 
associated with protein kinase B (Akt) and cyclic adenosine monophosphate response 
element (CRE) binding protein (CREB)-mediated signaling (Hardingham et al, 2002; 
Jantas et al, 2009; Wang et al, 2012), whereas neuronal death is linked to the NOS and 
calpain pathway, among others (Lai et al, 2014; Wei et al, 2012; Zhou et al, 2008). 
Physiological patterns of NMDAR stimulation are required to ensure neuronal 
survival, whereas inhibition of NMDAR activity can cause neuronal death (Brenneman et 
al, 1990). Several downstream signaling pathways have been linked to NMDA receptor-
dependent survival (see Figure 1-2 for an overview). One route to neuronal survival is 
based on the induction of survival genes. Activation of NMDARs allows calcium to enter 
the cell, which can subsequently be transported to the cell soma and invade the nucleus. 
Nuclear Ca
2+
 can then activate the transcription factor CREB via the calmodulin kinase 
IV (CaMKIV) or the extracellular signal-regulated kinase (ERK) pathway. CREB in turn 
upregulates many pro-survival genes including brain-derived neurotrophic factor 
(BDNF), but can also inhibit the expression of death-signaling genes (Lai et al, 2014). 
Additional pro-survival genes, such as TNF-α and Calbindin, can be turned on by 
NMDAR-induced activation of NFκB (Hardingham and Bading, 2003). 
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Figure 1-2: General overview of pro-survival and pro-death signalling pathways associated with NMDA receptors. The pathways marked with a * are favoured 
by extrasynaptic NMDAR activation (Papadia and Hardingham, 2007), reprinted with permission from SAGE Publications, Inc. Journals. 
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Another important element for neuronal survival is the activation of the protein kinase 
Akt as a result of stimulation of phosphatidylinositol 3-kinase (PI3K) or activation of the 
calcium-calmodulin dependent protein kinase kinase. Akt in turn promotes neuronal 
survival through inhibition of several death-signaling proteins, including glycogen 
synthase kinase-3, the B-cell lymphoma 2 (BCL-2) family member BCL-2-associated 
death promotor and the forkhead transcription factor (Lai et al, 2014). Another 
mechanism through which physiological NMDAR activity can ensure neuronal survival 
is by enhancing protection against oxidative stress (Papadia et al, 2008). 
Pathological stimulation of NMDA receptors, resulting in disruption of intracellular 
calcium homeostasis, can cause neuronal death via apoptosis or necrosis depending on 
the intensity of the insult (see Figure 1-2 for an overview). Antagonism of NMDAR-
mediated survival pathways, such as dephosphorylation and therefore inactivation of 
CREB as well as ERK activity is an important mechanism in cell death (Hardingham and 
Bading, 2010). For example, excitotoxicity can recruit the death-associated protein kinase 
1, which can not only augment the activity of the NMDAR, but also inhibit the pro-
survival signaling mediated by ERK (Lai et al, 2014). Furthermore, the NR2 subunit has 
been shown to interact with PSD95. Through interaction with neuronal NOS, PSD95 can 
couple NMDAR activity to NO toxicity (Aarts et al, 2002; Sattler et al, 1999). NO can 
trigger lipid peroxidation and deoxyribonucleic acid (DNA) damage as well as inhibit 
pro-survival mechanisms (Lai et al, 2014; Sattler and Tymianski, 2001). Other important 
pathways involved in neuronal death include activation of the calpain signaling cascade, 
which causes the cleavage of essential cellular proteins, and stimulation of members of 
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the mitogen-activated protein kinase family, stress-signaling proteins such as p38 and c-
Jun N-terminal kinase that regulate pro-death signaling genes (Lai et al, 2014). 
 
1.5 ACETYLCHOLINE AND ACETYLCHOLINE RECEPTORS 
Acetylcholine (ACh) is an endogenous neurotransmitter, located in both the central 
nervous system and the peripheral nervous system. While ACh acts as a fast-acting 
neurotransmitter at neuromuscular junctions in the peripheral nervous system, it seems to 
function mainly as a neuromodulator in the brain. In addition to engaging in classical 
synaptic transmission between presynaptic and postsynaptic neurons, acetylcholine can 
also influence neuronal excitability in the CNS, modulate presynaptic neurotransmitter 
release, and coordinate the firing of groups of neurons (Picciotto et al, 2012).  
Acetylcholine is formed by the enzyme choline acetyltransferase from acetyl 
coenzyme A and choline. The postsynaptic action of ACh is terminated by the hydrolytic 
enzyme acetylcholinesterase (AChE), which hydrolyzes acetylcholine into acetate and 
choline resulting in the rapid decrease of ACh concentrations in the extrasynaptic 
compartment. Choline is normally taken up by high affinity Na
+
-choline transporters 
present in most cholinergic nerve terminals (Colović et al, 2013), however, some ACh 
receptors can be activated by choline alone (Alkondon et al, 1997b). 
As a neuromodulator, ACh plays an important role in brain development, learning, 
memory, and attention, regulating neuronal excitability via two main receptor classes, the 
ligand-gated nicotinic ACh receptor (nAChR) channels or G protein-coupled muscarinic 
ACh receptors (Dani and Bertrand, 2007). The two receptor types are named after their 
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sensitivity to the plant molecules nicotine and muscarine, respectively (Albuquerque et 
al, 2009). Dysfunction of the cholinergic system has been implicated in neuronal 
degeneration and cognitive deficits in diseases such as AD, schizophrenia, and 
Parkinson’s disease (Hurst et al, 2013; Resende and Adhikari, 2009). 
1.5.1 Nicotinic acetylcholine receptors 
Nicotinic receptors are ligand-gated ion channels and occur as homomeric or 
heteromeric assemblies of five transmembrane subunits. A variety of distinct nAChR 
subunits (α1-10, β1-4, γ, δ, ε) have been identified so far (Pohanka, 2012). The α8 
subunit, however, has not yet been found in mammalian tissue (Dani and Bertrand, 
2007).  Different combinations of these subunits are possible, leading to a wide variety of 
possible nicotinic receptor subtypes displaying distinct pharmacological properties and 
functions.  
Neuronal nicotinic receptors typically consist of a combination of α and β subunits or 
of α subunits only (α7 or α9).  While the α7 subunit seems to predominantly form 
homopentameric receptors, some evidence suggests that other subunits, such as β2, can 
combine with the α7 to form a heteromeric receptor (Murray et al, 2012). The most 
common nAChR subtypes in the mammalian brain are receptors containing α4β2 or 
homomeric α7 subtypes (Pohanka, 2012). The α7 receptor is expressed at high levels in 
the hippocampus, hypothalamus, amygdala, cerebral cortex, and olfactory areas (Séguéla 
et al, 1993).  
While nicotinic receptors can be found at postsynaptic sites in the CNS (Alkondon et 
al, 1998; Roerig et al, 1997), most nAChRs seem to be presynaptic (Gray et al, 1996; 
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McGehee et al, 1995) consistent with their role as neuromodulators. Some nAChRs are 
also found at the surface of cell bodies and axons (Arroyo-Jimenez et al, 1999; Hill et al, 
1993; Kawai et al, 2007). The ligand binding site is located between α subunits and select 
non-α subunits or at the interface of two α subunits as is the case for the homomeric α7 
nAChR. Once the ligand binds to the binding site, the nicotinic receptor undergoes a 
sequence of conformational changes from a resting to an activated state leading to the 
opening of the ion channel pore. Because the activated state of the receptor is unstable, 
further conformational changes occur and lead to a non-conducting desensitized state 
(Papke, 2014). Many channels will initially open with high probability upon agonist 
binding. However, desensitized channels will begin to accumulate and remain in the 
desensitized state, decreasing the probability of further opening of channels with agonist 
binding until levels of ligand occupancy are decreased by diffusion or metabolism of the 
transmitter (Papke, 2014). When open, the nicotinic receptor channel allows the influx of 
sodium and potassium, and depending on the subunit composition it can also be 
permeable to Ca
2+
 (Dani and Bertrand, 2007).  
The subunit composition of nicotinic receptors, which is highly variable due to a 
wide range of possible combinations, determines the electrophysiological and 
pharmacological characteristics, and thus the receptor’s role in the CNS. Nicotinic 
acetylcholine receptors have the ability to modulate the release of other 
neurotransmitters, including Glu and gamma-aminobutyric acid (GABA), as well as to 
directly depolarise postsynaptic neurons (Albuquerque et al, 2009). Hence, nAChRs can 
have a wide range of functions. As the α7 nAChR is central to this thesis, its 
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physiological function and involvement in neuropathological diseases will be discussed 
in more detail. 
1.5.2 The α7 nicotinic acetylcholine receptor 
Among the different nicotinic acetylcholine receptors, the α7 nAChR in particular is  
implicated in cognitive functions of the CNS and thought to have important clinical 
implications for diseases such as AD and schizophrenia (Conejero-Goldberg et al, 2008). 
The α7 subunit is one of the most prevalent nicotinic receptor subunits in the CNS and is 
thought to be expressed mainly as a homomeric receptor. However, they have also been 
shown to form functional receptors with other subunits (Anand et al, 1993; Liu et al, 
2009; Mowrey et al, 2013; Murray et al, 2012). In the hippocampus, nAChRs can be 
found at particularly high levels, with the α4β2 and the α7 receptors representing the 
most common nicotinic receptors in this area (Adams et al, 2002; Fabian-Fine et al, 
2001; Séguéla et al, 1993). Furthermore, functional α7 nAChRs are expressed throughout 
hippocampal subregions such as the dentate gyrus (DG), CA1, and CA3 (Adams et al, 
2002; Fabian-Fine et al, 2001; Sudweeks and Yakel, 2000). Ultrastructural studies of the 
rat hippocampus provided evidence that α7 nAChRs are present at both presynaptic and 
postsynaptic sites (Fabian-Fine et al, 2001). Additionally, non-neuronal cells may also 
express α7 nAChRs. For example, Shen and Yakel (2012) have shown that α7 nAChRs 
can be localized on astrocytes in acute hippocampal slices. 
In comparison with other nicotinic receptors, the α7 nAChR has unique 
pharmacological properties. For example, it is not only permeable to sodium, but also 
shows a high calcium permeability (Bertrand et al, 1993; Fayuk and Yakel, 2005), which 
suggests it may have a similar role to NMDA receptors in synaptic plasticity (Cheng and 
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Yakel, 2015). Other characteristics include short channel open times, fast desensitization 
kinetics and low affinity for ACh (Mike et al, 2000). The α7 nAChR is activated by ACh 
and selectively by its metabolite choline (Alkondon et al, 1997b). 
The α7 nAChR can also influence intracellular calcium levels, either directly through 
voltage activated channels via activation of ERK1/2 (Dajas-Bailador et al, 2002a) or 
indirectly from intracellular sources following nicotinic ryanodine receptor channel 
activation (Dajas-Bailador et al, 2002b). The α7 nAChR-mediated rise in Ca2+ levels can 
induce neurotransmitter release (Koukouli and Maskos, 2015), including Glu (Aramakis 
and Metherate, 1998) and GABA (Guo et al, 1998). 
Drugs that potentiate central cholinergic transmission are currently the main 
treatment strategy for symptoms of diseases characterized by cognitive impairment, 
including AD and schizophrenia. Many studies provide evidence for the involvement of 
α7 nAChRs in cognitive functions of the CNS. Several selective α7 nAChR agonists have 
been shown to improve attention, learning, and memory in both animals and humans 
(Cincotta et al, 2008; Thomsen et al, 2010). Furthermore, inhibition of α7 nAChR-
mediated signaling using antagonists such as methyllycaconitine may impair working 
memory function but not reference memory function in rats (Levin et al, 2002), 
suggesting that α7 nAChRs may preferentially impact particular forms of memory over 
others.  
With regards to clinical importance, altered expression and activity of α7 nAChRs 
appears to be involved in cognitive deficits characterized in patients with schizophrenia 
(Adler et al, 1998; Freedman et al, 1995), Alzheimer’s disease (Burghaus et al, 2000; 
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Hellström-Lindahl et al, 1999; Yu et al, 2005), and Parkinson’s disease (Banerjee et al, 
2000). For example, Olincy et al (2006) conducted a proof-of-concept trial of 3-[(2,4-
dimethoxy) benzylidene]anabaseine (DMXB-A), a partial α7 nAChR agonist, in 
schizophrenia patients. Administration of DMXB-A was able to improve cognitive 
functions such as attention and memory, as measured by a specific test battery for the 
assessment of neuropsychological status. The cognitive improvement abilities of α7 
nAChRs have also been demonstrated in animal models of AD (Medeiros et al, 2014; 
Prickaerts et al, 2012). Given this promising data from preclinical models, several 
compounds that enhance α7 nAChR activation are currently undergoing clinical trials for 
the treatment of AD and schizophrenia (Wallace and Porter, 2011).  
An alternative approach to increase α7 nAChR function is to sensitize these receptors 
to activation by the endogenous agonist ACh using allosteric potentiating ligands (APLs) 
such as galantamine (Santos et al, 2002). Because of its distinct desensitization kinetics 
and low sensitivity to ACh, the α7 nAChR is a perfect candidate for allosteric modulation 
(Dani and Bertrand, 2007; Williams et al, 2011). Galantamine is currently available for 
treatment of mild to moderate cognitive impairments in AD due to its actions as an 
inhibitor of AChE (Deardorff et al, 2015). At lower concentrations, however, 
galantamine can also act as an α7 nAChR APL (Maelicke and Albuquerque, 1996; 
Pereira et al, 2002; Samochocki et al, 2003; Storch et al, 1995). Using a mouse model of 
AD, Bhattacharya et al (2014) have demonstrated improvement of cognitive and 
behavioural symptoms following galantamine administration as well as potential disease-
modifying and neuroprotective properties of galantamine. For example, galantamine 
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treatment was able to decrease the density of amyloid beta (Aβ) placques in the 
hippocampus of affected mice. 
However, α7 nAChRs also have neurotoxic properties. One of the hallmark signs of 
AD is the accumulation of the abnormally folded protein Aβ, particularly the 42-amino-
acid form Aβ1-42. These Aβ oligomers are thought to impair neuronal function and 
cognition (Danysz and Parsons, 2012). The α7 nAChR can bind directly to Aβ (Wang et 
al, 2000a, 2000b), which may contribute to cell death in the pathogenesis of AD 
(Conejero-Goldberg et al, 2008).  
Additionally, α7 nAChRs can be linked to neurotoxicity in the absence of other 
disease mechanisms. For example, stimulation of α7 nAChRs in PC12 cells, a rat cell line 
derived from a neuroendocrine tumor of the adrenal medulla, has been shown to induce 
neuronal survival as well as neuronal death depending on the degree of activation through 
activation of different intracellular transduction processes (Li et al, 1999). 
 
1.6 INTERACTION BETWEEN NMDA RECEPTORS AND Α7 NICOTINIC 
RECEPTORS 
NMDA receptors and α7 nicotinic acetylcholine receptors are ligand-gated ion 
channels permeable to calcium and other ions. Both receptor types are expressed in the 
hippocampus. Physiologically, they are thought to be involved in cognitive processes, 
such as synaptic plasticity, learning and memory. However, both nicotinic receptor-
mediated mechanisms and NMDAR dysfunction have been implicated in various 
neuropathological diseases.  
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The properties and function of NMDARs and α7 nAChRs are dependent on subunit 
composition. Additionally, receptor phosphorylation, interaction with intracellular 
proteins, and interaction with GPCRs can influence the activity of these ligand-gated ion 
channels (Li et al, 2014). For example, protein kinase C-mediated phosphorylation can 
regulate NMDAR function (Chen and Huang, 1992; Wang et al, 2014), whereas 
dephosphorylation of α7 nAChRs by tyrosine kinases appears to enhance receptor 
activity and expression (Cho et al, 2005; Wiesner and Fuhrer, 2006) 
Recent experiments have provided evidence that different types of ion channel 
receptors can also directly interact with each other, possibly affecting receptor function. 
In a co-immunoprecipitation experiment, Li et al (2012) identified the presence of a 
complex between NMDARs, in particular the NR2A subunit, and α7 nAChRs in rat 
hippocampal tissue in vivo. Functional implications of disruption of the α7 nAChRs-
NMDAR interaction using a specifically engineered protein peptide included reduced 
ERK activity and changes in behavior related to nicotine dependence. A follow-up study 
addressed questions about the functional effects of this receptor interaction. NMDAR-
dependent miniature excitatory postsynaptic currents were enhanced by exposure to 
choline, a selective α7 receptor agonist. This effect was abolished by administration of 
the aforementioned interfering peptide, demonstrating that the α7 nAChR-NR2A 
interaction is essential for modulation of NMDAR function. In the same study, 
behavioural tests in mice indicated an important role of this complex in non-spatial 
learning and memory (Li et al, 2013).  
A functional interaction between α7 nAChRs and NMDARs in physiological and 
pathophysiological events has been reported in previous publications. For example, 
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presynaptic stimulation of α7 nAChRs is known to facilitate glutamatergic transmission 
(Girod et al, 2000). Furthermore, α7 nicotinic receptors can influence presynaptic 
NMDAR expression (Lin et al, 2010). Zappettini et al (2014) not only provided 
immunocytochemical evidence for the co-localization of α7 nAChRs and NMDARs in 
the nucleus accumbens of rats, but also showed that choline-induced stimulation of α7 
nicotinic receptors potentiates the function of NR2A-containing NMDA receptors. 
With regards to NMDA-induced excitotoxicity, activation of α7 nAChR has been 
shown to have neuroprotective properties in acute hippocampal slices (Ferchmin et al, 
2003), in neocortical cultures, and in rat models of focal ischemia (Shimohama et al, 
1998). Some evidence exists to support the neuroprotective effect of choline pre-
treatment 72 h prior to NMDA administration in organotypic hippocampal slice cultures 
(Mulholland et al, 2004). On the other hand, over-activation of this receptor subtype has 
been suggested to be neurotoxic. For example, exposure to high doses of the partial 
nicotinic agonists DMXB have been shown to induce cell death via α7 nicotinic receptors 
(Li et al, 1999). Additionally, α7 nAChRs were implicated in neurotoxic effects in a 
human neuroblastoma cell line (Guerra-Álvarez et al, 2015) and in a model of 
glutamatergic injury (Laudenbach et al, 2002).  
 
1.7 ORGANOTYPIC HIPPOCAMPAL SLICE CULTURES  
In vitro cell cultures are an important addition to in vivo animal models of stroke, as 
they allow for high throughput screening and study of molecular signaling pathways in a 
tightly regulated environment, while also reducing the number of animals used. Primary 
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dissociated cell cultures of neurons or other brain cell types are a commonly used tool in 
research, but have the disadvantage that many characteristics of the in vivo situation, such 
as connections to other cells and cell types, are not replicated. In contrast, organotypic 
brain slice cultures preserve the structural and cellular organization of the tissue and 
uphold synaptic connections from the original tissue (Cho et al, 2007). Easy experimental 
access and the possibility for exact regulation of the extracellular environment are 
additional advantages. These make organotypic brain slice cultures a viable alternative to 
the intact animal, combining the complexity of the in vivo context with the ability to 
regulate the extracellular environment.  
Brain slice cultures have been successfully prepared from a wide range of brain 
regions, including hippocampus (Wang and Andreasson, 2010), cortex (Kang and 
Morrison, 2015), cerebellum (Campeau et al, 2013), striatum (Jäderstad et al, 2010), and 
spinal cord (Mazzone et al, 2013). More recently, organotypic slice co-culture systems 
have been developed, which allow for the evaluation of inter-neuronal responses and 
functional relationships across brain regions (Guthrie et al, 2005). Especially organotypic 
hippocampal slice cultures (OHSCs) have been used extensively to study the 
development and functional role of the hippocampal formation (Gambrill and Barria, 
2011) as well as neuronal damage (Butler et al, 2010) and neuroprotection (Ring et al, 
2010).  
1.7.1 Hippocampus 
The hippocampus, a small sea-horse-shaped structure located in both hemispheres 
under the cerebral cortex, is an important part of the limbic system. It can be divided into 
two main parts: the DG and the hippocampus proper. The latter is also referred to as 
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Ammon’s horn, or cornu ammonis (CA), and consists of four different subfields 
designated CA1-4. There are other areas that are not considered a part of the 
hippocampus, but are closely associated with it, including the subiculum and the 
entorhinal cortex. Therefore, these regions are often combined under the term 
hippocampal formation (Parkin, 1996).  
Hippocampal neurons are interconnected by projections of excitatory neurons. 
Receiving input from the entorhinal cortex via the performant path, the DG sends 
excitatory axons, also called mossy fibers, to the CA3 region. Cells from CA3 then 
project further to the CA1 neurons via the Schaffer collaterals (Andersen et al, 1971). 
Functionally, the hippocampus is known to be involved in cognitive functions, such as 
learning and memory processes (Shapiro and Eichenbaum, 1999). The concept of LTP, 
which describes the strengthening of synapses caused by repeated patterns of synaptic 
activity, has been extensively studied in this brain structure. As a form of synaptic 
plasticity, LTP is believed to be one of the primary cellular mechanisms underlying 
learning and memory (Baudry et al, 2015).   
Glutamate receptors, particularly NMDA receptors, are thought to be involved in 
learning and memory processes (Bliss and Lomo, 1973). The importance of NMDA 
receptors in learning and synaptic plasticity is supported by experiments studying the 
effect of a NMDAR antagonist on behavioral effects of rats in certain learning tasks. 
Administration of the selective NMDA receptor antagonist 2-amino-5-phosphono-
pentanoic acid caused impairment of spatial learning as well as a total block of 
hippocampal LTP in vivo (Morris, 1989). NMDARs are expressed at high levels in the rat 
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hippocampus (Monaghan and Cotman, 1985; Moriyoshi et al, 1991), which also makes it 
an interesting region to study mechanisms of excitotoxicity.  
With importance to this thesis, the α7 nicotinic acetylcholine receptor is also highly 
expressed in the rat hippocampus (Adams et al, 2002; Séguéla et al, 1993), suggesting a 
potential involvement in regulating synaptic transmission, plasticity, and 
neurodegeneration (Fabian-Fine et al, 2001). For example, stimulation of α7 nAChRs has 
been shown to enhance LTP (Fujii et al, 1999; Hunter et al, 1994). This effect is possibly 
because of increased presynaptic release of Glu and postsynaptic depolarization, both of 
which can be mediated by the α7 nAChR (Cheng and Yakel, 2015; Ge and Dani, 2005). 
Furthermore, the presence of a complex between NMDA receptors and α7 nAChRs has 
initially been described in rat hippocampal tissue (Li et al, 2012, 2013). Therefore, the 
hippocampus is an appropriate region of the brain to investigate the potential interaction 
of NMDA receptors and α7 nAChRs with regards to excitotoxicity in organotypic slice 
cultures. 
1.7.2 Methodological aspects for the use of organotypic hippocampal slice cultures  
Several techniques have been developed over the years to prepare and maintain 
organotypic slices of brain tissue in long-term culture. The two predominant procedures 
are the roller tube technique and the membrane interface method. In organotypic cultures 
prepared by using a roller tube as described by Gähwiler (1981), brain tissue is attached 
to glass coverslips, embedded in plasma clots or collagen matrix and incubated in slowly 
rotating culture tubes. A very unique characteristic of these roller-tube cultures is the 
monolayer aspect, as the slice cultures flatten considerably after 2-3 weeks in vitro to 
approximately 50 µm, thus facilitating experiments where optimal optical conditions are 
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necessary (Gähwiler et al, 1997). However, the thinning of the tissue may generate large 
experimental variability, as overall health of the slice and diffusion distances are linked to 
slice thickness (Guy et al, 2011). The difficulty of the roller tube preparation method is 
an additional disadvantage (Cho et al, 2007). 
First described by Stoppini et al (1991), the membrane interface method has further 
increased the use of organotypic slice cultures due to the easier preparation procedure 
compared to the roller tube technique (Lossi et al, 2009). In membrane cultures, tissue 
slices are placed onto a semiporous membrane at the interface between humidified air 
and culture medium on the underside of the membrane. In contrast to roller-tube cultures, 
slice cultures grown by the interface method usually remain a few cell layers thick and 
flatten from an initial 400 µm to approximately 100-150 µm (Stoppini et al, 1991). Brain 
slices prepared by either technique preserve many essential characteristics of the original 
tissue, including proper morpho-anatomical organisation, structural integrity, neuronal 
connectivity, and glial-neuronal interactions, and can be maintained in culture for fairly 
long periods of time (Bahr et al, 1995; Gähwiler et al, 1997). However, most recent 
experimental studies use adaptations of the membrane interface method. 
Organotypic slice cultures are typically prepared from brains of animals at the early 
postnatal stage (postnatal day [PND] 0 to 12). At this age, the brain tissue has matured 
enough to establish cytoarchitectonic fundamentals and basic synaptic connections. 
Additionally, slice cultures prepared from postnatal brain tissue appear to be more 
resistant to mechanical trauma during the culturing procedure and exhibit a high degree 
of plasticity. In comparison to the embryonic stage, the larger size of postnatal brains also 
facilitates the culture preparation (Cho et al, 2007). More recently, efforts to use 
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adolescent or adult animals have been made, but the viability of these slices seems to 
decrease with age, making long-term culture difficult (Humpel, 2015a).  
Using OHSCs, it is also possible to reduce the number of experimental animals 
needed. Typically, about 20-25 slices can be obtained from a single donor animal. 
Multiple data points can be generated from cultures derived from each individual animal, 
thereby sparing a significant number of live animals.  
It is important to note the limitations of in vitro preparations including ways they 
deviate from in vivo conditions. For example, the CA1 region in organotypic 
hippocampal slices exhibits a more complex pattern of dendritic branching than observed 
in vivo. Additionally, in vitro preparations exhibit a significant increase in the frequency 
of glutamatergic miniature synaptic currents, suggesting that there are an increased 
number of total synapses in vitro. However, during subsequent stages of culture, 
maturation and development in the in vitro conditions almost entirely match development 
observed in vivo  (De Simoni et al, 2003).  
Collectively, OHSCs offer a highly effective compromise between complex in vivo 
models and monolayers in vitro cultures. As they preserve many of the in vivo 
characteristics and permit the precise control of the extracellular environment, 
organotypic hippocampal slice cultures represent an important tool for the study of 
neurophysiological and pathophysiological questions. 
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1.7.3 Rationale to use organotypic hippocampal slice cultures as an in vitro model 
of excitotoxicity 
Organotypic hippocampal slice cultures have not only been commonly used to 
investigate physiological functions of the hippocampus, but also to study mechanisms of 
neuronal death underlying diseases, including stroke, epilepsy, or Alzheimer’s disease. 
Oxygen-glucose deprivation and administration of excitotoxins (Ahlgren et al, 2011; 
Bruno et al, 1994; Wise-Faberowski et al, 2009a) are the two most common models of 
ischemia and stroke in organotypic slice cultures. While administration of excitotoxins 
such as Glu or NMDA only models one aspect of the ischemic cascade, it permits the 
investigation of the involvement of specific GluRs (Noraberg et al, 2005).  
In addition to preserving the cytoarchitecture of the tissue, organotypic hippocampal 
slice cultures have been shown to stably express NMDA receptors and other GluRs in 
long-term culture conditions despite an initial small decrease in expression after tissue 
cutting (Bahr et al, 1995). Furthermore, the expression of various NMDAR subunits in 
OHSCs is comparable to expression levels in vivo, and NMDARs expressed in cultures 
are functional and can induce excitotoxic cell death (Ahlgren et al, 2011). 
The hippocampus also expresses α7 nAChRs at high levels (Adams et al, 2002; 
Fabian-Fine et al, 2001). Importantly, expression of α7 nAChRs is maintained in OHSCs 
(Mielke and Mealing, 2009). Therefore, OHSCs present a valuable in vitro model for the 
investigation of the potential interaction between α7 nAChRs and NMDARs after 
excitotoxic insult.  
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1.8 EXPERIMENTAL RATIONALE, HYPOTHESIS AND STUDY OBJECTIVES 
While physiological activation of NMDA receptors is necessary for neuronal 
survival, over-activation of NMDA receptors by excess levels of glutamate leads to rapid 
neuronal cell death by excitotoxicity. This process is believed to be the underlying cause 
of neurodegeneration following stroke. Recent literature has suggested a possible 
interaction between NMDARs and α7 nAChRs, but the exact role of α7 nAChRs in 
mediating excitotoxicity is still unclear with reports of nAChRs being both neurotoxic 
and neuroprotective in certain systems. The aim of this thesis was to investigate the 
possible interaction between NMDARs and α7 nAChRs in vitro using organotypic 
hippocampal slice cultures. 
The hypothesis for this thesis is that co-activation of α7 nicotinic acetylcholine 
receptors alters NMDA-induced neurotoxicity in organotypic hippocampal slice cultures. 
Using OHSCs, the primary objectives for research outlined within this thesis were 
twofold: 
1) To develop a method to objectively quantify cell death in organotypic 
hippocampal slice cultures using propidium iodide (PI) exclusion 
2) To establish a dose-response curve for NMDA toxicity 
3) To determine the effects of co-activation of α7 nicotinic acetylcholine receptors 
on NMDA-mediated excitotoxicity 
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CHAPTER 2: 
DEVELOPMENT OF A METHOD TO OBJECTIVELY QUANTIFY CELL 
DEATH IN ORGANOTYPIC HIPPOCAMPAL SLICE CULTURES USING 
PROPIDIUM IODIDE 
 
A modified version of this chapter is published as: Happ,D.F., Tasker, R.A., A method 
for objectively quantifying propidium iodide exclusion in organotypic hippocampal 
slice cultures. Journal of Neuroscience Methods 269 (2016) 1-5 
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SUMMARY 
Organotypic hippocampal slice cultures retain the normal hippocampal 
cytoarchitecture, function, and cellular diversity observed in vivo, and therefore present 
an attractive in vitro model to investigate physiological functions of the hippocampus as 
well as mechanisms of neuronal death. OHSCs have been increasingly used to study 
mechanisms of neurotoxicity underlying neuropathological diseases such as stroke by 
either oxygen-glucose deprivation or exposure to excitotoxins such as NMDA. The 
fluorescent dye propidium iodide is a commonly used marker for membrane integrity and 
cell injury. However, no standardized format for quantifying PI uptake in OHSCs exists. 
In the study presented in this chapter, organotypic hippocampal slice cultures were 
prepared from 5-6 day old rats according to the interface method and maintained for 13 
days. After confirming viability, slices were exposed for 4 hours to varying 
concentrations of NMDA and re-evaluated by PI exclusion after 24 hours in fresh media. 
To quantify PI uptake, subfields were separated using simple landmarks and 
densitometric quantification of PI fluorescence intensity in 10 template-oriented counting 
fields. This protocol describes a simple method to objectively quantify cell death in 
OHSCs. The method provides a standardized format, is applicable to cultures of differing 
shapes and sizes, and permits comparisons between hippocampal subfields. This method 
was therefore deemed to be appropriate to use for studying the effects of receptor 
interaction in the following chapters of this thesis.  
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2.1 INTRODUCTION 
During an ischemic stroke, a complex series of multiple cellular events is triggered 
(see Chapter 1, Section 1.4). The current hypothesis is that lack of blood flow restricting 
oxygen and glucose exchange leads to depletion of energy, which impairs cellular ion 
pumps, resulting in cell depolarization. As voltage-dependent calcium channels become 
activated, excitatory neurotransmitters such as Glu are released into the extracellular 
space and accumulate due to failure of energy-dependent reuptake mechanisms (Dirnagl 
and Endres, 2014).  
Glu is the main excitatory neurotransmitter in the mammalian CNS. Through 
activation of ionotropic receptors and a family of G-protein coupled metabotropic 
receptors, Glu is involved in numerous processes during brain development as well as 
physiological function throughout life. Despite its critical role in normal brain 
development and function, over-activation of the Glu system can lead to rapid cell death 
in the CNS by a process called excitotoxicity (Meldrum, 2000).  
During an ischemic attack, the excessive extracellular levels of Glu can over-
stimulate NMDA and AMPA receptors resulting in a massive influx of divalent cations, 
especially Ca
2+
. Due to their high Ca
2+
 permeability, NMDARs contribute greatly to the 
intracellular calcium overload, which may subsequently activate signaling cascades 
causing neuronal cell death. NMDAR-mediated calcium influx is associated with 
cytotoxicity in many pathological states, including brain ischemia, traumatic brain injury, 
and multiple neurological diseases such as AD, Parkinson’s Disease, and amyotrophic 
lateral sclerosis (Dong et al, 2009; Szydlowska and Tymianski, 2010).  
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Many clinical trials investigating the neuroprotective potential of drugs, such as 
NMDAR inhibitors, have been unsuccessful, arguably due to lack of sufficient pre-
clinical data (Ginsberg, 2008). The traditional approach to pre-clinical characterisation of 
potential drugs – extensive in vivo testing in animal models – has some significant 
drawbacks, including lengthy animal surgery to model the neuropathology of stroke, and 
laborious monitoring of physiological parameters following in vivo manipulation (Cho et 
al, 2007). The use of in vitro cell culture preparations, such as organotypic slice cultures, 
may present an alternative to in vivo models for the study of pathological mechanisms 
underlying neurodegenerative diseases (Humpel, 2015b).  
Organotypic hippocampal slice cultures have become a valuable in vitro preparation 
to study a wide range of CNS functions including mechanisms of neurotoxicity. This is 
mainly because they offer unique advantages over other in vitro models such as primary 
dissociated cultures. OHSCs can be maintained in vitro for several weeks and, 
importantly, the slice cultures replicate many aspects of the in vivo context as they largely 
preserve the normal cytoarchitecture of the hippocampus and maintain intact neuronal 
activities (Cho et al, 2007). Furthermore, this system provides good pharmacological 
accessibility and allows for exact control of the extracellular environment, which 
simplifies the scientific correlation between molecular changes and neuropathological 
outcomes (Bernaudin et al, 1998). Therefore, OHSCs present an attractive and more 
easily manipulated alternative to studying the hippocampus in vivo. 
Organotypic slice cultures have been successfully established from a variety of CNS 
regions, including cerebral cortex, striatum, and cerebellum. The hippocampus is of 
particular interest as this region of the brain is known to be susceptible to Glu-mediated 
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signaling and excitotoxicity. Due to extensive multidisciplinary research, this area of the 
brain is also the best characterized in slice cultures (Lossi et al, 2009). Slice cultures 
prepared from the hippocampus not only retain the hippocampal architecture, but they 
also preserve the intrinsic connectivity between the hippocampal regions DG, CA3, and 
CA1 (Gutiérrez and Heinemann, 1999). Additionally, Gerace et al (2012) have shown 
that the distribution of Glu receptors is very similar to that observed in situ. 
With relevance to this thesis, OHSCs have been used increasingly for the 
investigation of mechanisms of neuronal damage underlying neuropathological diseases 
such as stroke. To mimic the events after an ischemic-hypoxic insult, OHSCs are 
commonly subjected to either oxygen glucose deprivation or exposure to excitotoxins 
such as NMDA. In this way, slice cultures are oftentimes used for screening of 
therapeutic molecules or novel genes (Abdel-Hamid and Tymianski, 1997; Kleczkowska 
et al, 2015). 
There are numerous methods to study cell death in OHSCs. These techniques include 
fluorescent staining (e.g. PI, Hoechst 33342, Fluoro-Jade), enzymatic assays (e.g. 
measuring the amount of lactate dehydrogenase (LDH) released into the media from 
damaged cells), and ultrastructural analysis. The cell impermeable dye PI is one of the 
most commonly used measures of neuronal death. Compared to healthy neurons, 
damaged or dead cells have compromised membrane integrity, allowing otherwise 
membrane-impermeable molecules to pass through. The polar compound PI readily 
enters neurons with damaged membranes and, once inside, binds to nucleic acids. It 
intercalates with DNA with a stoichiometry of one dye molecule per 4-5 base pairs with 
little sequence preference, rendering the dye to fluoresce brightly red (Cho et al, 2007; 
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Hezel et al, 2012; Noraberg et al, 1999). PI is considered to be non-toxic to neurons, and 
its uncomplicated application makes it a popular method to assess neuronal cell death. 
Although PI incorporation has been commonly employed as a marker for membrane 
integrity and cell viability in OHSCs and other in vivo preparations for decades, there is 
considerable variability in the methods used to measure and quantify PI. In older studies, 
PI uptake was frequently assessed qualitatively or semi-quantitatively using nominal 
scales (e.g. 0-4) to score toxicity of compounds (Liu et al, 2003; Simantov et al, 1999). 
Another technique to quantify PI labeling in OHSCs was to transform images after 
thresholding analysis to binary displays. This way, PI-positive cells were presented as 
white pixels over black background pixels, and cell death could be assessed by counting 
pixels (Kasof et al, 1995). Similar measures based on binary images of PI fluorescence 
intensity are occasionally still used today (Katayama et al, 2012). With the advancement 
of microscopes and imaging software, cell counting can also be performed without the 
transformation into binary images (Radley et al, 2012; Wise-Faberowski et al, 2009b).  
With the advance of computer imaging software, the most commonly used measure 
to objectively assess PI uptake is based on the quantitative densitometric analysis. 
However, a review of the current literature reveals a lack of consistency in the reported 
methods. Some authors suggest measuring gray-level intensity (Laake et al, 1999) as 
opposed to measuring fluorescence intensity directly. Cell damage can be calculated as 
the percentage of the total area labeled PI-positive (Kreutz et al, 2011) or as the 
percentage of the regional area in which PI fluorescence was detected using defined 
regions of interest within hippocampal subregions (Graulich et al, 2002). Furthermore, PI 
uptake has also been reported as the percentage of fluorescence intensity of control 
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groups (Butler et al, 2013; Gregersen et al, 2013; Lutz et al, 2015; Smith et al, 2010) or, 
more commonly, as the percentage of maximal fluorescence intensity. Various methods 
have been described to acquire terminal images representing maximal PI fluorescence 
intensity and therefore 100% cell death, including superfusion with 100 µM NMDA for 1 
hour (Kim et al, 2015; Kleczkowska et al, 2015; Xu et al, 2003), exposure to 50 mM Glu 
for 1 h (Noraberg et al, 1999), and low-temperature exposure (4°C) for 24 hours (Allard 
et al, 2015). However, the induction of maximal cell death for each slice has the 
disadvantage that treated slice cultures cannot be used for other subsequent procedures, 
such as protein isolation or immunohistochemical staining, after the insult.  
The specific objective of this study was to develop a simple and reproducible method 
to objectively quantify cell death in OHSC using PI exclusion with a standardized format. 
To demonstrate the utility of the method we used exposure to varying concentrations of 
the excitotoxin NMDA. 
 
2.2 METHODS 
2.2.1 Experimental animals 
Offspring born in-house from untimed pregnant Sprague-Dawley rats (Charles River, 
Quebec, Canada) were used to prepare the organotypic hippocampal slice cultures. After 
arrival at the facility, dams were housed individually with ad libitum access to water and 
Purina Rodent Chow. The housing facility was maintained at approximately 22°C under a 
12 h light-dark cycle (lights on at 06:00, off at 18:00). The day of parturition was 
designated as PND0. Animals were left undisturbed until the day of culturing on PND5/6. 
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Studies were carried out under approval from the University of Prince Edward Island 
Animal Care Committee, and were in accordance with the Canadian Council on Animal 
Care guidelines. 
2.2.2 Preparation and maintenance of organotypic hippocampal slice cultures 
The slice cultures were prepared according to the interface method of Stoppini et al 
(1991) with minor modifications. On PND5/6, rat pups were quickly decapitated, and the 
brain was removed and hippocampus dissected under aseptic conditions. The two 
hippocampi were dissected consecutively and stored temporarily in ice cold dissection 
medium containing 1% penicillin/streptomycin-solution (Gibco, NY, USA), 25 mM 
HEPES (pH 7.2-7.5, Fisher Scientific, NJ, USA) and 10 mM Tris (pH 7.2-7.3; Fisher 
Scientific) in Minimum Essential Media (MEM; Gibco, USA). The dissected hippocampi 
were straightened and transversely sliced throughout the entire length into 400 µm 
sections using a mechanical tissue chopper (Stoelting, IL, USA). The slices were 
immediately transferred into ice cold dissection medium. Slices were then separated by 
gently pipetting the tissue up and down using a plastic transfer pipette. Under a light 
microscope, slices with intact hippocampal morphology were placed onto 0.4 µm porous 
Millipore inserts (Millipore, MA, USA). Any excess medium from the top of the insert 
was suctioned off. Membrane inserts containing three slices each were transferred to 
individual 35 mm cell culture dishes (Fisher Scientific) filled with 1 ml of serum-based 
medium containing 50% MEM, 25% Hank’s balanced salt solution (Gibco), 12 mM 
HEPES, 25% heat-inactivated horse serum (Gibco), and 1% penicillin-streptomycin 
solution. Slice cultures were incubated in a humidified chamber at 37ºC in 5% CO2 for 13 
days to allow for good adherence to the membrane and the loss of any dead or damaged 
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cells on the surface of the slices. The media was changed the day after preparing cultures 
and then every three days. 
2.2.3 Assessing viability using propidium iodide 
At 13 days in vitro (DIV13) and before any experiments, OHSCs were exposed to PI 
(5 µg/ml; Sigma-Aldrich, MO, USA) for 30 minutes to assess cell culture viability. Using 
a Fluoroarc exciter lamp with a Zeiss Axioplan2 microscope equipped with a standard 
rhodamine filter, PI uptake was recorded with an AxioCam HR digital camera (Carl Zeiss 
Canada Ltd, ON, Canada) at this and subsequent stages. All images were taken with a 5× 
objective. The camera was connected to a computer loaded with the Axiovision Software 
as provided by the manufacturer. To ensure consistency and proper comparability of 
experimental results, the same exposure settings were used during all experiments (see 
Table 2-1). Slice cultures displaying distinct PI fluorescence were excluded from further 
experiments. PI-negative slices, however, were exposed to the indicated treatment 
conditions. 
Table 2-1: Fluorescence microscope settings for propidium iodide imaging 
Exposure time 22.1 ms / 104% 
Brightness -0.5 
Contrast 1.00 
Slope 1.07 
Color offset 0.00 
Saturation 1.0 
 
2.2.4 Drug application 
Healthy OHSCs, as determined by PI uptake (see above), were exposed to different 
concentrations of NMDA (Sigma-Aldrich) (1 µM, 10 µM, 50 µM, 100 µM, 500 µM and 
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1 mM) in 0.9% saline, or to 0.9% saline alone as control for 4 hours. Slice cultures were 
then transferred to fresh culture medium for 24 hours. After this 24 hour period, PI 
uptake was measured again to determine the effects of drug exposure on cell viability. 
Additionally, light microscope pictures of each slice were taken to facilitate identification 
of hippocampal structures. Negative control slices were exposed to the same amount of 
saline. To serve as positive controls, OHSCs were exposed to ice cold 70% ethanol for 24 
hours at -20°C. A minimum of 6 slices were analysed and averaged per treatment 
condition with rat pup as the unit of variance. 
2.2.5 Image analysis and quantification of PI fluorescence 
The digital pictures of propidium iodide uptake taken by the fluorescence 
microscope (1300×1030 pixels) were analyzed by densitometry with the public domain 
Java image processing program ImageJ® inspired by NIH Image (National Institute of 
Health, MD, USA) for the Macintosh. 
Because of the irregularly shaped and sized slice cultures, a standardized method of 
quantifying PI uptake was needed to be able to consistently compare cell viability. For 
this reason, a standard template of 9 movable, circular regions of interest, with three in 
each of the hippocampal regions (DG, CA3 and CA1), was developed (see Figure 2-1). 
Within the ImageJ software, the circles were specified as 80×80 pixels. Using 
conventional landmarks, the hippocampal subfields were identified. To facilitate optical 
separation of the hippocampal regions, a straight line was drawn connecting the two arms 
of the DG and extending through the cornu ammonis area. In order to standardize the 
placing of the measuring fields, the first circle was placed at the midpoint of each region, 
with the other two circles placed equally distant from the midpoint and the boundaries.
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Figure 2-1: Standard template for quantification of propidium iodide. Representative illustration shows placement of measurement windows in the hippocampal areas 
(dentate gyrus, CA3 and CA1) of propidium iodide-stained organotypic hippocampal slice cultures. 
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Additionally, a tenth circle was placed adjacent to the slice culture to allow for 
subtraction of any background noise. The raw integrated density, the sum of the pixel 
values, was calculated for every circle of each slice.  
The PI uptake recorded after low temperature exposure to 70% ethanol represented 
maximum cell death. In this way, the PI uptake induced by NMDA exposure could be 
expressed as the percentage of the maximal PI uptake. 
2.2.6 Data analysis 
All densitometric data were expressed as mean ± standard error of the mean (SEM). 
The dose-response-curve for NMDA-induced excitotoxicity was created with 5-12 slices 
from 5-7 different preparations (n=5-7). Statistical significance was assessed in SPSS 
Statistics Version 23 (IBM Corporation, NY, USA). 
A one-way analysis of variance (ANOVA) followed by a Games-Howell procedure 
was conducted to determine the effect of increasing NMDA concentrations on the 
combined cell death for the whole slice culture. Two-way mixed factorial ANOVA was 
used to compare PI uptake among the different hippocampal regions DG, CA1, and CA3. 
Post-hoc tests were performed with the Games-Howell procedure. Subsequently, effects 
of drug exposure on cell viability were analyzed for each hippocampal region separately 
using one-way ANOVA followed by the Games-Howell procedure. Differences were 
considered significant at p<0.05. 
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2.3 RESULTS 
2.3.1 Dose dependent excitotoxic effects of NMDA 
Hippocampal structure in all organotypic slice cultures included in the analysis was 
well preserved and PI uptake was very low before agonist exposure. Normality of the 
data was confirmed (p=0.200) using the Kolmogorov-Smirnov test. Levene’s test of 
equality of error variances was significant (F6,35=4.56, p=0.002) Therefore, Welch’s F 
ratio was used to determine the significance of the ANOVA and the Games-Howell 
procedure was selected to investigate between-group differences.  
Cell death varied significantly in slice cultures exposed to different concentrations of 
NMDA based on ANOVA (F6,35= 7.1746, p<0.0005). In control cultures treated with 
saline, cell death occurred spontaneously on a small scale with a basal PI uptake of 
4.28% ± 0.38 (n=5). As shown in Figure 2-2, slice cultures treated with NMDA (1-1000 
µM) for 4 hours revealed a dose-dependent increase in PI uptake when data from all 
hippocampal subfields as recorded 24 hours later were combined. Addition of 1 µM 
NMDA to the culture medium resulted in a significant increase in the level of PI 
incorporation compared to the control group (8.26% ± 0.44, n=6, p=0.001). PI uptake 
further progressed with increasing concentrations of NMDA (26.81% ± 2.89, n=7, 
p=0.002; 37.18% ± 6.14, n=6, p=0.024; 38.54% ± 5.06, n=6, p=0.009; 31.26% ± 3.85, 
n=6, p=0.007; 47.42% ± 2.82, n=6, p<0.0005 for 10, 50, 100, 500 and 1000 µM NMDA, 
respectively). The levels of PI fluorescence intensity after exposure to 10, 50, 100, 500 
and 1000 µM NMDA were also significantly different from slice cultures treated with 1 
µM NMDA. Furthermore, PI uptake was significantly increased in slices exposed to 1000 
µM NMDA compared to OHSC exposed to 10 µM NMDA (p=0.005). However, there   
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Figure 2-2: Dose-response relationship between increasing concentrations of NMDA and propidium iodide 
(PI) uptake measured for the entire hippocampal slice culture. Maximal cell death (100%) was measured in 
OHSCs exposed to 70% ethanol for 24 h at -20°C. Data are shown as means ± SEM, with n = 5–7, Different 
letters indicate significant differences between groups (p<0.05) using one-way ANOVA with Games-Howell 
procedure. The value of 0.01 μM NMDA represents saline as a control. 
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was no significant difference between cell death in slice cultures exposed to 50, 100, 500 
or 1000 µM NMDA. 
2.3.2 Differential susceptibility of hippocampal subfields to NMDA 
The hippocampus has been shown to exhibit region-specific vulnerability to various types 
of insults (Kosuge et al, 2008; Stanika et al, 2010). In order to determine whether there 
was an interaction between NMDA concentration and hippocampal region, the data were 
analyzed using a one-way ANOVA with repeated measures design (with the hippocampal 
regions DG, CA3, and CA1 as within-subject factors). Figure 2-3 shows the dose-
response relationship for NMDA in the three hippocampal subfields, DG, CA1, and CA3. 
Mauchly’s test of sphericity was significant (p<0.0005) and therefore the Greenhouse-
Geisser correction was used to assess the F-value. A significant difference between 
hippocampal regions was found (F1.33,45.61=136.54, p<0.0005). Pairwise comparisons 
using Bonferroni adjustment revealed that each hippocampal region was significantly 
different from each other (p≤0.001). Therefore, the hippocampal subfields were 
subsequently analyzed separately using one-way ANOVA (Welch’s F-value) followed by 
Games-Howell procedure as Levene’s test for homogeneity of variance was significant 
for all three regions (DG: p=0.021; CA1: p<0.0005; CA3: p=0.002). The general trends 
observed in the combined values are reflected in the individual regions. A significant 
effect of NMDA concentration was found in all three regions (DG: F6,35=44.206, 
p<0.0005; CA3: F6,35=42.955, p<0.0005; CA1: F6,35=52.466, p<0.0005). However, higher 
values of PI uptake were generally observed in the CA1 region compared to CA3 and DG 
(see Table 2-2 for a summary of all the values).  
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Figure 2-3: Dose–response relationship between increasing concentrations of NMDA and cellular propidium 
iodide (PI) uptake, measured for the hippocampal subregions separately. The maximal PI uptake after 24 h low-
temperature exposure to 70% ethanol was set to 100%. Data are shown as means ± SEM, with n = 5–7. The value 
of 0.01 μM NMDA represents saline as a control. Using a one-way ANOVA with repeated measures design, a 
significant difference between hippocampal regions was found (F1.33,45.61=136.54, p<0.0005). * indicates the first 
concentration to be significantly different (p<0.05) from saline treated control cultures in the respective region, 
with following asterisks omitted for clarity. 
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Table 2-2: Propidium iodide uptake in the dentate gyrus (DG) and CA3 and CA1 hippocampal regions in organotypic slice cultures treated with increasing 
concentrations of NMDA or saline as negative control for 4 hours, as recorded after 24 h in fresh media. Data expressed as percentage of positive control exposed to 70% 
ethanol at low temperature for 24 h (mean ± SEM). a indicates significance (p<0.05) from saline, b from 1 μM NMDA, c from 10 μM NMDA and d from 500 μM NMDA 
in the respective region. 
 CA1 CA3 DG 
Saline 5.21 ± 0.58 2.98 ± 0.36 4.62 ± 0.38 
1 µM NMDA 11.51 ± 1.47a 4.59 ± 0.20 8.60 ± 0.61a 
10 µM NMDA 43.70 ± 4.60a,b 22.61 ± 3.08a,b 13.98 ± 1.94 
50 µM NMDA 52.99 ± 7.66a,b 27.60 ± 5.20a,b 30.69 ± 5.87a 
100 µM NMDA 57.33 ± 9.45a,b 27.62 ± 3.36a,b 30.40 ± 3.41a,b,c 
500 µM NMDA 43.29 ± 4.39a,b 20.86 ± 3.49a,b 29.37 ± 4.44a,b 
1000 µM NMDA 59.30 ± 3.91a,b 37.68 ± 2.5a,b,c,d 45.03 ± 2.85a,b,c 
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In the DG, a basal PI uptake of 4.62% ± 0.38 (n=5) was observed in the saline-
treated cultures. Figure 2-3 shows the increase in PI uptake for slice cultures treated with 
NMDA (1-1000 µM). Addition of 1 µM NMDA to the culture medium resulted in a 
significant increase in the level of PI incorporation compared to the control group (8.59% 
± 0.61, n=6, p=0.006). Increasing concentrations of NMDA induced significantly higher 
levels of PI incorporation (13.98% ± 1.94, n=7, p=0.024; 30.69% ± 5.87, n=6, p=0.051; 
30.40% ± 3.41, n=6, p=0.005; 29.37% ± 4.44, n=6, p=0.020; 45.03% ± 2.85, n=6, 
p<0.0005 for 10, 50, 100, 500 and 1000 µM NMDA, respectively).  
There was no significant difference in PI uptake between control OHSCs (2.98% ± 
0.36, n=5) and slices treated with 1 µM NMDA (4.59% ± 0.20, n=6, p=0.061) in the CA3 
region. However, addition of higher concentrations of NMDA revealed significant 
differences in PI uptake (22.61% ± 3.08, n=7, p=0.006; 27.60% ± 5.20, n=6, p=0.040; 
27.62% ± 3.36, n=6, p=0.006; 20.86% ± 3.49, n=6, p=0.029; for 10, 50, 100 and 500, 
respectively), but did not exceed 37.68% ± 2.50 after exposure to 1000 µM NMDA (n=6, 
p<0.0005). PI uptake in the CA3 region generally seems to be lower when compared to 
the DG. 
The highest PI uptake of 59.30% ± 3.91 was recorded in the CA1 region after 
treatment with 1000 µM NMDA (n=6, p<0.0005 from control). Slice cultures treated 
with saline (5.21% ± 0.58, n=5) or 1 µM NMDA (11.51% ± 1.47, n=6, p=0.054) did not 
exhibit significant differences in PI uptake. However, levels of PI uptake differed 
significantly in slice cultures treated with higher doses of NMDA (43.70% ± 4.60, n=7, 
p=0.024; 52.99% ± 7.66, n=6, p=0.051; 57.33% ± 9.45, n=6, p=0.005; 43.29% ± 4.39, 
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n=6, p=0.020; for 10, 50, 100 and 500 µM NMDA, respectively) compared to control 
slices. 
 
2.4 DISCUSSION 
Many neuropathological and neurodegenerative diseases, including stroke, traumatic 
brain injury and AD, are associated with neuronal cell death as a result of Glu -mediated 
excitotoxicity. Elevations of extracellular Glu over-activate ionotropic NMDA receptors 
leading to massive calcium influx, mitochondrial dysfunction, and the formation of 
reactive oxygen species, which contribute to the ongoing cell death (Durukan and 
Tatlisumak, 2007). Organotypic hippocampal slice cultures are a valuable alternative to 
in vivo models to investigate the toxic effects of excessive Glu levels in the brain (Ring et 
al, 2010). One way to evaluate the outcome of neurotoxicity is to expose slice cultures to 
excitotoxins such as NMDA. The fluorescent dye PI can only enter damaged or dead 
cells due to their comprised membrane integrity and is therefore a frequently used marker 
of cell injury. Various protocols to assess PI uptake have been reported in the literature 
(Butler et al, 2013; Katayama et al, 2012; Wise-Faberowski et al, 2009b), but there is a 
substantial inconsistency in the methods used. 
Therefore, the aim of this study was to develop a method to objectively quantify PI 
uptake in OHSCs that is simple, reproducible, and provides a standardized means of 
measuring cell death in hippocampal subfields. Slice cultures were exposed to varying 
concentrations of NMDA to illustrate the value of the devised method. 
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The principal findings of this study were two-fold. First, exposure to increasing 
concentrations of NMDA produced a dose-dependent increase in PI fluorescence 
intensity and therefore cell death in OHSCs. This effect was found in all hippocampal 
subfields. Second, comparison of PI uptake in the three subfields CA1, CA3, and DG 
showed a region-specific vulnerability of the hippocampus to NMDA-mediated cell 
death, with the CA1 area being the most sensitive. Both of these findings are consistent 
with previously published results (Ikegaya and Matsuki, 2002; Kristensen et al, 2001). 
The hippocampus is one of the regions in the brain most vulnerable to ischemia, and 
the selective susceptibility of the hippocampal subfields to certain insults is a common 
theme in the literature. First described in histological studies of epileptic brains by 
Sommer (1880), the characteristic vulnerability of certain areas of the hippocampus to 
injury has since been observed clinically (Bartsch et al, 2015; Hatanpaa et al, 2014) and 
has also been replicated in experimental animal models, including gerbils (Bonnekoh et 
al, 1990), rats (Jarrard and Meldrum, 1993), cats (Schmidt-Kastner et al, 1990), and 
monkeys (Lavenex et al, 2011), in vivo and in vitro (Kosuge et al, 2008; Stanika et al, 
2010). Together, all these studies have shown that the CA1 subfield of the hippocampus 
seems to be the most susceptible region to ischemic insults, whereas the DG and CA3 
area appear to be more resistant. However, there may be differences in the distinct pattern 
of vulnerability depending on the neurotoxin used, as Ikegaya and Matsuki (2002) 
showed the selective vulnerability of CA1 neurons to NMDA, CA3 neurons to kainic 
acid, and DG region to colchicine. 
Although the ischemic cascade causing neuronal cell death has been delineated, the 
mechanisms underlying this distinctive pattern of susceptibility to injury are not well 
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understood. The two main hypotheses trying to explain regional differences in 
vulnerability, originally developed by Spielmeyer (1927) and Vogt and Vogt (1937),  
propose either variations in hippocampal vasculature or intrinsic differences in 
physiological and biochemical properties of neurons respectively as primary causes. 
Because experiments performed in hippocampal slice cultures, which are separated from 
blood supply, still showed patterns of selective vulnerability, the concept of intrinsic 
differences prevails (Bernaudin et al, 1998; Newell et al, 1990).   
Glu-mediated excitotoxicity is an important part of the ischemic cascade, and 
therefore the specific expression pattern of Glu type receptors has been of immense 
interest. Coultrap et al (2005) showed that expression of the NMDA receptor subunits 
NR1 and NR2B differs among the hippocampal regions. For example, there is a greater 
expression of NR2B in the CA1 versus the CA3 or DG. This may have important 
functional implications, as various NMDAR characteristics such as channel opening, 
Ca
2+
 entry and agonist affinities are dependent on the subunit composition (Burnashev et 
al, 1995; Chen et al, 1999; Laube et al, 1997) (see Section 1.4). Experiments conducted 
by Butler et al (2010) confirmed the greater density of the NR1 and NR2B subunit in 
CA1 relative to DG and CA3. Using an in vitro oxygen-glucose deprivation model, this 
ischemic insult has been shown to modulate NMDA responses in CA1 and CA3 neurons 
via a tyrosine kinase phosphorylation, which may underlie the differential susceptibility 
of CA1 compared to CA3 (Gee et al, 2006). 
Additional factors may be involved in the selective vulnerability of hippocampal 
neurons, including differences in endoplasmic reticulum stress-induced neurotoxicity 
(Kosuge et al, 2008), in neuronal NOS expression (Black et al, 1995) and calcium-
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mediated mitochondrial dysfunction (Friberg et al, 1999; Stanika et al, 2010). Besides 
neuron-neuron interactions, connections between neurons and glia cells may also be 
implicated (Bernaudin et al, 1998).  Due to their Glu reuptake mechanisms, astrocytes 
have the ability to regulate extracellular levels of Glu. Hence, the role of astrocytes with 
regards to the characteristic susceptibility of CA1 neurons has also been studied. After 
transient forebrain ischemia in rats, the loss of Glu uptake activity of astrocytes in the 
CA1 region, which is in part due to mitochondrial dysfunction and oxidative damage in 
CA1 astrocytes, can contribute to the selective vulnerability of CA1 neurons (Ouyang et 
al, 2007). Furthermore, astrocytes from adult monkey hippocampal tissue exhibit lower 
astrocytic coverage of excitatory synapses as well as lower expression level of genes 
linked to Glu uptake and metabolism or glycolysis in CA1 versus CA3, causing the CA1 
region to be more vulnerable to ischemic insults (Lavenex et al, 2011).  
Although densitometric analysis of PI fluorescence intensity is currently the most 
commonly used method to evaluate cell death in organotypic hippocampal slice cultures, 
various measures have been developed, including the enzymatic MTT assay (Wise-
Faberowski et al, 2009b), or counterstaining methods to compute a ratio of the number of 
dead vs live cells. Radley et al (2012), for example, used Hoechst labeling, which stains 
cell nuclei, to acquire the total number of cells and then calculated the percentage of cell 
death as cells stained with PI divided by the total amount. Double-labeling with PI and 
fluorescein diacetate, as a measure of enzyme activity, is another commonly used 
counterstaining method (Sato and Matsuki, 2002). There has been an ongoing debate in 
the literature whether this approach gives a more accurate depiction of cell death – 
compared to only counting dead cells in the culture – as it may take differences in cell 
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density in OHSCs into account. However, measurement of cell death by PI uptake was 
shown to agree with manual cell counting of live vs dead cells (Newell et al, 1995). 
Additionally, the value of PI fluorescence intensity seems to correlate with other markers 
of neuronal loss, including LDH efflux, Nissl cell staining, and Fluoro-Jade staining 
(Noraberg et al, 1999). Furthermore, Abdel-Hamid and Tymianski (1997) showed that 
mean PI fluorescence intensity is linearly related to the number of pyknotic nuclei, a 
histological indicator for cell degeneration, in organotypic hippocampal slice cultures. PI 
uptake is therefore a viable measure of neurotoxicity in organotypic slice cultures (Cho et 
al, 2007; Noraberg et al, 1999). 
PI fluorescence intensity is often reported as the percentage of maximum PI uptake 
or cell death in order to compare different treatment conditions to each other. Among 
other methods, a terminal image representing maximal PI uptake and thus maximum cell 
death can be acquired by exposure of the same slice culture to high concentrations of Glu 
or other excitotoxins such as NMDA (Kleczkowska et al, 2015; Noraberg et al, 1999), 
low temperature exposure for 24 hours (Abdel-Hamid and Tymianski, 1997; Allard et al, 
2015), or exposure to Triton X-100 (Sato and Matsuki, 2002). This way, PI uptake in 
OHSCs after exposure to a specific treatment can be expressed as a relative percentage of 
the maximal possible fluorescence intensity. However, the induction of maximal cell 
death has the disadvantage that treated slice cultures cannot be used for subsequent 
procedures after the insult, such as protein isolation or immunohistochemical staining. 
The protocol defined in this chapter offers the advantage that mean maximal PI uptake 
can be determined using only a subset of the cultures. The percent maximal uptake for 
cultures in the varying treatment groups can then be calculated subsequently without the 
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induction of maximal cell death. This way PI uptake can still be assessed objectively on a 
continuous scale with minimal variability. Additionally, it allows for the possibility to use 
the same slice culture not only to assess the effects of a specific treatment on cell 
viability, but also on protein or gene expression using techniques such as protein 
isolation, western blotting, and immunohistochemical staining. Consequently, multiple 
data points can be generated from slice cultures derived from each individual animal, 
which can reduce the number of animals used to obtain comprehensive information. 
A potential issue to note in this study is the entry mechanism of PI. As mentioned 
above, PI can enter cells that have a damaged or leaky cell membrane. Therefore, PI 
fluorescence has not only been correlated with other markers of neuronal cell loss, but it 
is also an indicator of membrane integrity. It is possible that some neurons have a 
damaged cell membrane and die later than 24 hours after the switch to fresh media, 
whereas other neurons may recover and survive after initial uptake of PI (Mayer et al, 
2002). However, previous literature has shown that PI uptake correlates well with a 
variety of different markers of cell death in organotypic hippocampal slice cultures 
(Noraberg et al, 1999). Furthermore, a study by Sato and Matsuki (2002) demonstrated 
the selective vulnerability of the hippocampus even when cell density was accounted for 
by double labelling with PI and fluorescein diacetate (Sato and Matsuki, 2002). Studies 
by Tymianski et al (1993a, 1993b) also suggest that NMDA and other agonists of NMDA 
receptors cause rapidly occurring neuronal degeneration that can be complete within 
hours. Therefore it is likely that the results reflect actual cell death. 
The method described in this thesis also offers the possibility to cater to differing 
dimensions of individual slices. Due to inherent differences in hippocampal form and 
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because organotypic hippocampal slice cultures are growing in vitro without any 
constraint from surrounding brain areas, the size and shape of the cultures varies even 
between replicates. Standardized landmarks facilitate the separation of the slice culture 
into the three hippocampal subfields, given that the arms of the DG are visible. 
Additionally, the location of regions of interest can be adjusted in order to accommodate 
different shapes of OHSCs. Owing to the fact that regional indicators are necessary, the 
use of this method is limited to the analysis of cell death in organotypic cultures and is 
not applicable to dissociated cell cultures.  
Using this method, a dose-dependent increase in PI uptake was observed after 
exposure to increasing concentrations of NMDA. Interestingly, administration of doses as 
high as 1 mM NMDA did not exceed 50% and 60% of maximal PI uptake, when 
measured for the entire hippocampal slice culture and for the CA1 region, respectively. 
This is in contrast to other authors who report a PI uptake of 75-100% after exposure to 
similar or lower concentrations of NMDA (Kristensen et al, 2001; Ring et al, 2010; 
Sakaguchi et al, 1997). However, only about 30% cell death in CA1 after exposure to 1 
mM NMDA was reported in a recent study by Kleczkowska et al (2015). The authors 
also claim that frequently used concentrations of NMDA (100 µM) did not induce 
damage in organotypic hippocampal slice cultures. This discrepancy in PI uptake 
following exposure to NMDA may be due to variations in experimental procedures, such 
as distinctions in culture medium, exposure timing, or conceivably the method of 
standardizing cell death. Kristensen et al (2001), for example, exposed OHSCs to 50 mM 
Glu to acquire maximal PI fluorescence intensity, whereas maximal PI uptake was 
assessed after 24 hour low-temperature exposure to 70% ethanol in this study or after 
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treatment with supramaximal concentrations of NMDA in the study conducted by 
Kleczkowska et al (2015). The potential reason for this is unclear, but a possible 
explanation for this discrepancy is the composition of OHSCs and a potential implication 
of glial cell death in the measurement of maximal PI uptake. Organotypic slice cultures 
are not only made up of neuronal cells, but also glial cells. In comparison to neurons, 
glial cells generally are more resistant to ischemic insults (Goldberg and Choi, 1993). 
However, they are susceptible to cell injury mediated by exposure to ethanol or extremely 
high doses of NMDA (Holownia et al, 1997). Hence, depending on the method to induce 
maximal cell death, the measure of maximal PI uptake is based on the death of neurons 
alone versus the death of neurons and glial cells combined. In the current study, about 
50% PI uptake was measured after treatment with 1 mM NMDA. This value most likely 
indicates 100% neuronal damage, as exposure to this concentration of NMDA 
presumably does not affect or only minimally affects the population of glial cells 
(compare Appendix D). A similar conclusion was drawn by Abdel-Hamid and Tymianski 
(1997). In their experiments, 60 minutes of oxygen-glucose deprivation result in almost 
complete degeneration of neurons in OHSCs as confirmed by histology, which accounted 
for about 40% of maximal PI fluorescence achieved by exposure to NMDA and kainic 
acid followed by low-temperature exposure for 24 h.  
To further explore the potential implication of glial cell death in the maximal PI 
uptake, double-label immunohistochemistry with the neuronal marker NeuN and glial 
fibrillary acidic protein (GFAP) was performed on untreated OHSCs fixed in formalin 
and stored in ethylene glycol at -20°C (see Appendix D). The results indicate that the 
ratio of neuronal to glial cells is about 50/50. This ratio, however, seems to vary between 
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hippocampal subfields. It is possible that the differences in glial cell numbers may 
contribute to regional differences, but further in-depth studies are needed to confirm this 
hypothesis. 
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CHAPTER 3: 
EVALUATION OF INTERACTION OF NMDA RECEPTORS AND Α7 
NICOTINIC ACETYLCHOLINE RECEPTORS 
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SUMMARY 
Physiological activation of ionotropic NMDA receptors by glutamate plays an 
important role during brain development and physiological functioning throughout life. 
However, excess levels of Glu can over-activate synaptic and extrasynaptic NMDA 
receptors leading to rapid neuronal cell death by a process called excitotoxicity. This 
pathological mechanism is largely responsible for cell death in many neuropathological 
diseases, including stroke. Many recent publications have indicated a possible interaction 
between NMDA receptors and nicotinergic signaling via alpha7 nicotinic acetylcholine 
receptors (α7 nAChRs). The potential role of nAChRs in mediating Glu toxicity, 
however, is somewhat controversial with reports of nAChRs being both neuroprotective 
and neurotoxic in certain systems. To investigate the possible interaction between NMDA 
receptors and α7 nAChRs in vitro, organotypic hippocampal slice cultures were prepared 
from 5-6 day old Sprague-Dawley rats and maintained for 13 days on semiporous 
membrane inserts at 37°C. The contribution of α7 nAChRs in NMDA-mediated 
excitotoxicity was characterized by administering NMDA in combination with the 
specific α7 nAChR agonist choline and the APL galantamine. The results obtained show 
that co-activation of α7 nAChRs does not significantly alter NMDA-induced excitotoxic 
cell damage in OHSCs. However, activation of α7 nicotinic receptors alone significantly 
increased cell death in some hippocampal regions as measured by PI uptake, suggesting a 
possible neurotoxic effect that would require further investigation. 
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3.1 INTRODUCTION 
Stroke is one of the most frequent causes of death, disability, and economic expense 
worldwide. The majority of stroke cases are ischemic strokes, caused by the interruption 
of blood flow to the brain (Go et al, 2013). The only currently approved drug treatment 
for ischemic strokes is the use of thrombolytic drugs, such as tissue plasminogen 
activator (tPA). These drugs aim to dissolve the blood clot to remove the blockage and 
therefore restore cerebral blood flow. The time window for treatment with tPA is 4.5 h 
after the onset of stroke symptoms (del Zoppo et al, 2009). Due to its narrow therapeutic 
window and numerous contraindications, only about 5% of patients receive intravenous 
thrombolysis within the appropriate time window (Balami et al, 2013; Moretti et al, 
2015; Pandya et al, 2011). 
Many different approaches to find new treatment strategies for ischemic strokes have 
been made over the years, but they have been ultimately unsuccessful. For example, 
preclinical trials testing NMDA receptor antagonists, anti-inflammatory agents, and 
antioxidants were quite promising, but failed in clinical testing (O’Collins et al, 2006). A 
better understanding of excitotoxicity in ischemic stroke and the underlying pathological 
mechanisms as well as validation of novel potential neuroprotective agents in appropriate 
models are necessary to address the lack of effective treatments for ischemic stroke.  
The loss of blood supply in the brain causes cell death by initiating the ischemic 
cascade. These pathophysiological events occur within minutes of the vascular occlusion. 
The order of these events is difficult to determine, as many events demonstrate 
overlapping features. Although the initial insult can lead to brain damage very rapidly, 
ischemic brain injury may last hours or even days (Durukan and Tatlisumak, 2007).  
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Diminished blood flow leads to the depletion of oxygen and glucose in ischemic 
brain tissue. Energy failure causes dysfunction of ATP-dependent ion pumps and 
subsequent ionic imbalance in the ischemic brain tissue, including elevation of 
intracellular sodium, calcium, and chloride as well as elevated levels of extracellular 
potassium (Durukan and Tatlisumak, 2007). Consequently, the neuronal membrane 
potential is lost resulting in the depolarization of neuronal and glial cells, resulting in the 
release of large amounts of Glu into the extracellular space. These excess levels over-
activate GluRs, particularly NMDA receptors, leading to further increases of intracellular 
concentrations of Ca
2+
, Na
+
, and Cl
-
 (Durukan and Tatlisumak, 2007).   
High intracellular Ca
2+
 levels are not only due to influx from extracellular sources, 
but calcium can also be released from intracellular storage, including endoplasmic 
reticulum (Pisani et al, 2000) or mitochondria (Webster, 2012). Calcium can trigger 
pathophysiological events by activating various Ca
2+
-dependent enzymes, such as protein 
kinase C, phospholipases, calpains and other proteases, cyclooxygenase, NOS, and 
endonucleases (Szydlowska and Tymianski, 2010; Xing et al, 2012). Furthermore, Ca
2+
-
mediated mitochondrial damage may trigger release of apoptotic and inflammatory 
mediators as well as free radical production (Turner et al, 2013).  
Several studies have demonstrated the importance of calcium in mediating the toxic 
effects of brain ischemia. Although the exact mechanisms remain controversial, it is 
commonly accepted that calcium overload through distinct entry routes can trigger 
specific second messenger pathways that initiate cell death mechanisms. More 
specifically, calcium entry  via voltage-gated Ca
2+
 channels is not associated with 
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ischemic damage, whereas nearly all members of the GluR family have been implicated 
in excitotoxicity (Szydlowska and Tymianski, 2010).  
The ionotropic NMDAR is of particular interest with regards to calcium toxicity and 
brain ischemia, as these receptors are highly permeable to Ca
2+
. NMDA receptors are 
voltage-dependent ion channels comprised of four subunits, which are a combination of 
NR1, NR2, and NR3 subunits. Most NMDA receptors in the mammalian CNS are 
assembled from two NR1 and two NR2 subunits (Traynelis et al, 2010). A unique 
characteristic of these classical NMDARs is the requirement for simultaneous binding of 
Glu and glycine to open the channel. Additionally, the channel pore is blocked by Mg
2+
 
at resting potential. Upon depolarization of the membrane, the Mg
2+
 block is removed 
and monovalent cations as well as divalent cations, especially Ca
2+
, can enter the cell 
(Kalia et al, 2008). 
NMDARs are widely distributed in the brain and are typically localized at 
postsynaptic sites. Because of the important role of NMDARs in synaptic transmission, 
neuronal maturation, and synaptic plasticity, the dysfunction of NMDAR-mediated 
signaling is thought to contribute to the pathophysiology of various neurological 
conditions, including stroke (Margaill et al, 1996) and AD (Danysz and Parsons, 2012). 
Distinct intracellular signaling mechanisms have been linked to both NMDAR-dependent 
neuronal survival and neuronal death. For example, NMDARs can promote neuronal 
survival by induction of pro-survival genes, such as BDNF (Soriano et al, 2006), or 
enhancing protection against oxidative stress (Papadia et al, 2008). In contrast, neuronal 
death can be induced by NMDAR-mediated inactivation of CREB, an important part of 
the pro-survival pathway, and activation of NOS (Hardingham et al, 2002). Receptor 
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location and subunit composition, as well as excessive NMDAR-dependent intracellular 
calcium levels, are implicated in regulating this dual mode of NMDA receptors 
(Hardingham et al, 2002; Liu et al, 2007; Stanika et al, 2010).  
Receptor function and activity of ligand-gated ion channels including the NMDAR is 
regulated by receptor phosphorylation (Smart, 1997) as well as by intracellular proteins 
and cell surface receptors like GPCRs through direct protein-protein coupling (Kim and 
Sheng, 2004; Lee et al, 2002). While functional dimerization has generally been 
established between GPCRs as well as between GPCRs and ligand-gated ion channels 
(Bulenger et al, 2005; Lee et al, 2002), Li et al (2012) recently reported the formation of 
a protein complex between two ligand-gated ion channels – the NMDA receptor and the 
α7 nicotinic acetylcholine receptor – through direct protein-protein interaction. A 
specifically developed interfering peptide was shown to be able to disrupt the formation 
of this complex, which resulted in changes in intracellular signaling pathways and rat 
behavior.  
Neuronal nicotinic acetylcholine receptors are pentameric ligand-gated ion channels 
made up of combinations of α and β subunits. In the mammalian brain, the majority of 
nicotinic receptors are assembled in either α4β2 or α7 configurations (Pohanka, 2012). 
Nicotinic receptors can present as homopentameric receptors, formed by five identical 
subunits. The α7 subunit, for example, is thought to be predominantly expressed as a 
homopentamer in the CNS, although co-assembly with other subunits is possible 
(Couturier et al, 1990; Murray et al, 2012).  
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Particularly high levels of the α7 nAChR can be found in the hippocampus, where 
functional α7 nAChRs are expressed throughout all hippocampal subregions. On a 
subcellular level, the majority of α7 nicotinic receptors are localized on the presynapse, 
but some α7 nAChRs can also be expressed at somatic, perisynaptic, or postsynaptic 
sites. Pharmacologically, α7 nAChR channels are unique in that they demonstrate a high 
permeability to Ca
2+
 - similar to NMDA receptors. Additionally, α7 nAChRs exhibit a 
rather low affinity for ACh, but can be activated with full efficacy by choline 
(Albuquerque et al, 2009). The endogenous choline concentration in the extracellular 
space is thought to be around 4 to 6 µM (Mike et al, 2000), while the intracellular 
concentrations as well as the amount of bound choline is much higher (Klein et al, 1998). 
Activity of α7 nAChRs can also be enhanced by application of APLs such as 
galantamine. Although galantamine also acts as an inhibitor of AChE, it has been shown 
to enhance the channel opening probability of nAChRs induced by relatively low 
concentrations of nicotinic agonists (Samochocki et al, 2000; Schrattenholz et al, 1996). 
However, galantamine lacks selectivity as it displays APL action on various neuronal 
nAChR subtypes, including α7, α4β2, and α3β4 (Samochocki et al, 2003).  
With regards to physiological function, α7 nAChRs have been implicated in the 
regulation of the release of neurotransmitters from presynaptic terminals, including 
GABA and Glu, in the hippocampus and in other areas of the brain (Alkondon et al, 
1997a; Gray et al, 1996; Guo et al, 1998). Evidence further suggests the ability to modify 
glutamatergic transmission at postsynaptic locations (Biton et al, 2007; Cheng and Yakel, 
2014). While calcium signaling mediated by presynaptic α7 nAChR can enhance Glu 
release, α7 nicotinic receptors located at the postsynapse have been suggested to initiate a 
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Ca
2+
 signal that can act via calmodulin to reduce the responsiveness of NMDA receptors 
(Fisher and Dani, 2000).   
Furthermore, the direct interaction between α7 nAChR and NMDAR has recently 
been reported, as mentioned above (Li et al, 2012). Follow-up work by the same group 
has further supported the functional importance of α7 nAChR-NMDAR coupling. 
Disruption of this α7 nAChR-NMDAR interaction by a specific interfering peptide 
caused impairments in novel object recognition in mice, suggesting that the complex 
affects NMDA-mediated function and some aspects of learning and memory (Li et al, 
2013).  
Although α7 nAChRs are implicated in Glu- and NMDAR-mediated signaling, the 
potential role of α7 nAChRs in excitotoxic mechanisms remains controversial as there are 
reports supporting both a neuroprotective and a neurotoxic role of α7 nAChRs in certain 
systems. For example, activation of α7 nicotinic receptors has been shown to promote 
neuroprotection against β-amyloid cytotoxicity (Kihara et al, 1997), oxidative stress 
(Cormier et al, 2003), and excitotoxicity (Shimohama et al, 1998). In contrast, α7 
nAChRs may also be involved in neurotoxicity such that over-activation of α7 nAChRs 
may cause toxic intracellular calcium concentrations triggering apoptotic signaling. For 
example, over-activation of α7 receptors has been shown to trigger cell death following 
application of high concentrations of a specific agonist in PC12 cells (Li et al, 1999). 
Furthermore, α7 nAChR-mediated neurotoxic effects have also been demonstrated in a 
murine model of glutamatergic injury (Laudenbach et al, 2002), and in a human 
neuroblastoma cell line (Guerra-Álvarez et al, 2015). 
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Given the primary role of NMDA receptor-mediated excitotoxicity in the ischemic 
injury process and the potential of α7 nAChRs to modulate NMDAR activity and 
function, it was of interest to determine whether co-activation of α7 nAChRs changes 
NMDA-induced neurotoxicity and could therefore be an achievable therapeutic approach 
for reducing brain damage following excitotoxic insults.  
Organotypic hippocampal slice cultures present an attractive in vitro model to 
investigate receptor function as they not only preserve many features of in vivo cells, but 
also allow precise control of the extracellular environment as well as ease of 
experimental access (Humpel, 2015b). Drugs can easily be applied to mimic the 
excitotoxic insult and to stimulate α7 nAChRs without the pharmacokinetic restrictions of 
in vivo models. Both NMDA receptors and α7 nAChRs are expressed in organotypic 
hippocampal slice cultures (Ahlgren et al, 2011; Mielke and Mealing, 2009). Previous 
literature has shown that OHSCs are an appropriate model to study excitotoxicity induced 
by GluRs. The method of measuring PI uptake as described in Chapter 2 allows for an 
objective and quantitative analysis of cell death to compare the effects of drug 
administration on cell viability in vitro (Noraberg et al, 1999; Zimmer et al, 2000). 
 
3.2 METHODS 
3.2.1 Experimental animals 
Offspring born in-house from untimed pregnant Sprague-Dawley rats (Charles River, 
Quebec, Canada) were used to prepare the organotypic hippocampal slice cultures. After 
arrival at the facility, dams were housed individually with ad libitum access to water and 
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Purina Rodent Chow. The housing facility was maintained at approximately 22°C under a 
12 h light-dark cycle (lights on at 06:00, off at 18:00). The day of parturition was 
designated as PND0. Animals were left undisturbed until the day of culturing on PND5/6. 
Studies were carried out under approval from the University of Prince Edward Island 
Animal Care Committee, and were in accordance with the Canadian Council on Animal 
Care guidelines. 
3.2.2 Preparation and maintenance of organotypic hippocampal slice cultures 
Organotypic hippocampal slice cultures were prepared as described in Chapter 2 (see 
Section 2.2.2). Briefly, 5-6 day old rat pups were quickly decapitated. The two 
hippocampi were dissected under aseptic conditions and transversely sliced into 400 µm 
sections using a tissue chopper (Stoelting, IL, USA). Under a light microscope, slices 
with intact hippocampal morphology were placed onto 0.4 µm porous membrane inserts 
(Millipore, MA, USA). Membrane inserts with three slices each were transferred to 
individual 35 mm cell culture dishes (Fisher Scientific, NJ, USA) filled with 1 ml of 
serum-based medium containing 50% MEM (Gibco, NY, USA), 25% Hank’s balanced 
salt solution, 25% heat-inactivated horse serum, 1% penicillin-streptomycin solution 
(Gibco, USA) and 12 mM HEPES (Fisher Scientific, USA). Slice cultures were 
incubated at 37°C in 5% CO2 until day 13 in vitro.  
3.2.3 Assessing viability in organotypic slice cultures 
Viability of slice cultures was assessed at DIV13 using PI (Sigma-Aldrich, MO, 
USA) and before any experiments to ensure only live and healthy OHSCs were used. 
OHSCs were exposed to PI (5 µg/ml) for 30 minutes. Using a Zeiss Axioplan2 
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microscope, cultures were examined and OHSCs with distinct PI uptake were excluded 
from further experiments.  
3.2.4 Drug application 
Based on the results of the dose-response curve constructed from experiments in 
Chapter 2 (see Section 2.3), concentrations of 10 µM and 50 µM of NMDA were chosen 
to investigate the interaction between α7 nAChRs and NMDA receptors. Cultures were 
exposed to a combination of NMDA with either different concentrations of choline alone 
(Sigma) (10 mM and 50 mM) or together with 10 µM galantamine (Sigma), with saline 
used as a negative control, to compare the effect of α7 nAChR co-activation to 
stimulation of NMDA receptors alone. Table 3-1 summarizes all treatment conditions. 
Data for the exposure conditions of saline, 10 µM NMDA, and 50 µM NMDA were used 
from Chapter 2. As described in Chapter 2 (see Section 2.2.4), OHSCs were exposed to 
drugs for 4 hours and were then transferred to fresh culture medium for 24 hours. After 
this 24 hour period, PI uptake was measured again to determine the effects of drug 
exposure on cell viability. Additionally, light microscope pictures of each slice were 
taken to facilitate identification of hippocampal structures.  
The maximum achievable PI uptake was acquired from cultures exposed to ice cold 
70% ethanol for 24 hours at -20°C, which represents maximal cell death. With this 
method, the PI uptake induced by drug treatment could be expressed as the ratio of the 
maximal PI uptake. A minimum of 6 slices were analysed and averaged per treatment 
condition with rat pup as the unit of variance. 
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Table 3-1: Summary of drug treatments 
Saline control groups Lower dose NMDA Higher dose NMDA  
Saline 10 µM NMDA 
 
50 µM NMDA 
 10 µM NMDA + saline 
 
50 µM NMDA + saline 
Saline + 10 mM choline 10 µM NMDA + 10 mM 
choline 
 
50 µM NMDA + 10 mM 
choline 
Saline + saline + 10 µM 
galantamine 
10 µM NMDA + 10 mM 
choline + 10 µM galantamine 
 
50 µM NMDA + 10 mM 
choline + 10 µM galantamine 
Saline + 50 mM choline 10 µM NMDA + 50 mM 
choline 
 
50 µM NMDA +50 mM 
choline 
 10 µM NMDA + 50 mM 
choline + 10 µM galantamine 
50 µM NMDA + 10 mM 
choline + 10 µM galantamine 
 
3.2.5 Image analysis and quantification of PI fluorescence 
Images taken after a 4 hour long drug treatment and 24 hours in fresh media were 
analyzed by densitometry with the imaging software ImageJ® (National Institute of 
Health, USA). The standard template of 9 circular regions of interest as described in 
Section 2.2.5 of Chapter 2 was applied to the images, and PI fluorescence intensity was 
measured in the three hippocampal subfields, namely DG, CA1 and CA3. A tenth circle 
placed adjacent to the slice culture allowed for background subtraction. The raw 
integrated density of each slice was calculated. PI uptake induced by drug treatment was 
expressed as percentage of the maximal PI uptake, determined by low temperature 
exposure to 70% ethanol. 
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3.2.6 Data analysis 
All densitometric data were expressed as mean ± SEM. As results of the dose-
response curve revealed differences in PI uptake between cultures exposed to saline, 10 
µM and 50 µM NMDA, the treatment conditions in this chapter were divided into three 
main groups (see Table 3-1: Summary of drug treatments) and cross comparisons 
between these groups were not of interest for this research. Therefore, data of these three 
groups were analyzed separately using a one-way ANOVA with Welch’s F-value. If 
differences were detected, the Games-Howell post-hoc multiple comparison test was 
applied. The high dose NMDA group in region CA1 was analyzed using a normal one-
way ANOVA, as Levene’s test of homogeneity of variance for this group was not 
significant (F5,29=1.273, p=0.302), followed by Tukey’s post-hoc test. Statistical analyses 
were performed using SPSS Statistics Version 23 (IBM Corporation, NY, USA) at a level 
of significance of 0.05. 
 
3.3 RESULTS 
Initial experiments were performed to assess the regional and dose-dependent effects 
of NMDA exposure on cell damage in DIV13 cultures (see Chapter 2, Section 2.3). A 
significant main effect of the dose of NMDA was found as increasing concentrations of 
NMDA induced significant increases in PI uptake. Furthermore, a significant interaction 
between hippocampal region and NMDA concentration was detected, with the CA1 
region being most sensitive to NMDA-induced injury. Due to this significant interaction, 
hippocampal subfields were subsequently analyzed separately. 
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Normality of the data was confirmed using the Kolmogorov-Smirnov test (p>0.05). 
In all regions, comparison of the different treatment groups (saline, lower dose NMDA 
and higher dose of NMDA) revealed that Levene’s test of homogeneity of variances was 
significant (p<0.05). Thus, Welch’s ANOVA was used to assess significance between 
groups (Tomarken and Serlin, 1986) followed by the Games-Howell post-hoc test. The 
only exception is the higher dose NMDA group in the CA1 region, where the Levene’s 
test was not significant (p=0.302). For this group, differences were assessed using one-
way ANOVA followed by Tukey’s post-hoc test. 
3.3.1 Saline control groups 
Comparisons of mean percent PI uptake in OHSCs exposed to saline alone or in 
combination with α7 nAChR agonists revealed a number of treatment effects (see Figure 
3-1 and Table 3-2). 
In the DG, a significant between groups effect was found using Welch’s ANOVA 
(F3,7.98=8.631, p=0.007). OHSCs exposed to saline alone exhibited PI uptake of 4.62% ± 
0.38 (n=5). Addition of saline and 10 µM galantamine to potentiate endogenously present 
choline resulted in a faint PI uptake as seen through the microscope, but this group was 
not significantly different from saline treated slice cultures (10.14% ± 2.16, n=6, 
p=0.165). Upon activation of α7 nicotinic receptors with choline, PI uptake and thus cell 
death seemed to increase. In cultures exposed to saline and low dose of choline, PI uptake 
was 15.03% ± 3.04 (n=5, p=0.084). Addition of 50 mM choline resulted in a significant 
increase compared to saline alone (16.48% ± 3.21, n=6, p=0.049). No significant 
differences between any other groups were found. 
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Figure 3-1: Cellular propidium iodide (PI) uptake measured in the three hippocampal regions (dentate gyrus [DG], CA1 and CA3) of organotypic hippocampal 
cultures after exposure to saline, saline (S) in combination with  either 10 mM choline (10C) or 50 mM choline (50C) or saline, saline and 10 μM galantamine (10G). 
The maximal PI uptake after 24 h low-temperature exposure to 70% ethanol was set to 100%. Data are shown as means ± SEM, with n = 5–6. One way ANOVA 
using Welch’s correction followed by Games-Howell post-hoc test revealed significant differences between the four saline control groups in all three hippocampal 
regions, *p<0.05 from saline. 
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Table 3-2: Comparison of PI uptake after exposure to saline in combination with α7 nicotinic receptor agonists 
in the dentate gyrus (DG), CA1 and CA3. Data are given as mean ± SEM.  
 DG CA1 CA3 
saline (S) 4.62% ± 0.38 5.21% ± 0.58 2.98% ± 0.36 
S + 10 mM choline (10 C) 15.03% ± 3.04  24.73% ± 4.81 8.23% ± 1.76 
S + 50 mM choline (50 C) 16.48% ± 3.21 22.64% ± 5.33 12.62% ± 2.71 
S + S + 10 µM galantamine (10 G) 10.14% ± 2.16 13.25% ± 2.71 4.49% ± 0.99 
 
A similar trend was seen in the CA3 hippocampal region (compare Figure 3-1). 
Welch’s ANOVA revealed significant differences between groups (F3,8.02=6.233, 
p=0.016). No differences in PI uptake were found between cultures exposed to saline 
(2.98% ± 0.36, n=5), saline and galantamine (4.49% ± 0.99, n=6, p=0.519) and saline in 
combination with 10 mM choline (8.23% ± 1.76, n=5, p=0.124). Addition of the higher 
concentration of choline appeared to induce an increased PI uptake, as values of 12.62% 
± 2.71 were measured approaching significance (n=6, p=0.056). The remaining 
comparisons revealed no significant differences. 
Analysis of PI uptake in the CA1 region also showed a significant effect of treatment 
condition using Welch’s ANOVA (F3,8.02=9.696, p=0.005). Similarly to the DG and CA3 
region, a low basal PI incorporation was detected after saline treatment (5.21% ± 0.58, 
n=5). Further addition of saline and 10 µM galantamine resulted in an apparent increase 
of PI uptake (Figure 3-1), but did not significantly differ from saline exposure alone 
(13.25% ± 2.71, n=6, p=0.105). A significant increase in PI uptake was measured in 
cultures in which α7 nicotinic receptors were stimulated with 10 mM choline (24.73% ± 
4.81, n=5, p=0.049). When the choline concentration was increased to 50 mM, cell death 
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of 22.64% ± 5.33 was measured, which was not significantly different from cultures 
exposed to saline alone or cultures exposed to the lower concentration of choline (n=6, 
p=0.076 and p=0.991, respectively). No significant differences between any other groups 
were found.  
 
3.3.2 Low dose of NMDA (10 µM) in combination with α7 nicotinic receptor 
agonist 
Figure 3-2 shows the effect of stimulation of α7 nAChRs in combination with 10 µM 
NMDA on cell death, using PI uptake as a marker, in the three hippocampal regions DG, 
CA1 and CA3 of DIV13 organotypic hippocampal slice cultures. The data are 
summarized in Table 3-3: Comparison of PI uptake after exposure to a low dose of 
NMDA in combination with α7 nicotinic receptor agonists in the dentate gyrus (DG), 
CA1 and CA3. Data are given as mean ± SEM. 
No significant effect of treatment conditions was found in the DG using Welch’s 
ANOVA (F5,13.718=0.707, p=0.628). OHSCs exposed to 10 µM NMDA showed a PI 
uptake of 13.98% ± 1.93 (n=7). As shown in the control groups, saline by itself did not 
induce PI uptake. Thus, addition of saline to NMDA did not affect the cell damage in 
slice cultures (15.47% ± 1.19, n=6). Co-activation of α7 nicotinic receptors was achieved 
using the specific agonist choline. Exposure of OHSCs to low dose (10 mM) of choline in 
combination with 10 µM NMDA resulted in PI incorporation of 21.26% ± 5.78 (n=6). 
Further potentiation of α7 nicotinic receptors using 10 µM galantamine did not change 
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the level of PI uptake (18.14% ± 2.48, n=6). A similar amount of cell death in slice 
cultures was measured after treatment with 10 µM NMDA in combination with a high  
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Figure 3-2: Effects of co-activation of α7 nicotinic acetylcholine receptors and NMDA receptors in organotypic hippocampal slice cultures. Histograms show quantification of cell 
damage using propidium iodide (PI) in the three hippocampal regions dentate gyrus (DG), CA3 and CA1 after application of 10 µM NMDA (10N) either alone or in combination 
with saline (S), 10 mM choline (10C), 50 mM choline (50C), 10 mM choline plus 10 µM galantamine (10G) and 50 mM choline plus 10 µM galantamine. Data are shown as means ± 
SEM, with n = 6–7. One way ANOVA using Welch’s correction revealed no significant differences in any of the three hippocampal regions. 
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Table 3-3: Comparison of PI uptake after exposure to a low dose of NMDA in combination with α7 nicotinic 
receptor agonists in the dentate gyrus (DG), CA1 and CA3. Data are given as mean ± SEM. 
 DG CA1 CA3 
10 µM NMDA (10 N) 13.96% ± 1.93 43.70% ± 4.6 22.61% ± 3.08 
10 N + saline 15.47% ± 1.19 43.51% ± 2.73 18.11% ± 2.78 
10 N + 10 mM choline (10 C) 21.26% ± 5.78  56.71% ± 8.66 22.32% ± 9.34 
10 N + 50 mM choline (50 C) 23.22% ± 6.72 56.76% ± 12.57 22.79% ± 6.13 
10 N + 10 C + 10 µM 
galantamine (10 G) 
18.15% ± 2.48 50.67% ± 8.23 15.91% ± 4.09 
10 N + 50 C + 10 G 17.26% ± 2.86 48.99% ± 8.24 11.23% ± 1.60 
 
dose (50 mM) choline with or without 10 µM galantamine (23.22% ± 6.72 and 17.26% ± 
2.86, respectively, with n=6 in both groups). Similar results were seen in the other two 
hippocampal regions CA1 and CA3. As in the DG, there was no main effect of treatment 
on cell death as measured by PI uptake using Welch’s ANOVA (F5,13.606=0.624, p=0.685 
for CA1 and F5,13.787=2.537, p=0.079 for CA3). As the CA1 has been shown to be the 
region most sensitive to NMDA -induced cell damage, the PI uptake was higher in this 
area compared to the DG and CA3. Mean PI uptake in DG, CA1 and CA3 are presented 
in Table 3-3 as well as in Figure 3-2 for each of the treatment groups. 
3.3.3 High dose of NMDA (50 µM) in combination with α7 nicotinic receptor 
agonist 
The effects of co-activation of α7 nAChRs on 50 µM NMDA-induced cell damage in the 
three hippocampal regions DG, CA1, and CA3 of DIV13 organotypic slice cultures are 
summarized in Figure 3-3. Similar to the results of the low dose NMDA group, analysis 
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with one way ANOVA using Welch’s correction revealed no significant effect of  
treatment in the DG (F5,11.734=2.479, p=0.093). Exposure of slice cultures to 50 µM 
NMDA resulted in PI uptake of 30.68% ± 5.87 (n=6). As shown in Figure 3-3, addition 
of saline to high dose NMDA did not affect the PI uptake in OHSCs (38.99% ± 1.17, 
n=6). Co-activation of α7 nicotinic receptors using low dose (10 mM) of choline in 
combination with 50 µM NMDA resulted in greater mean values for PI uptake compared 
to 50 µM NMDA and saline (55.40% ± 9.30, n=5 vs 38.99% ± 1.17, n=6). Further 
potentiation of α7 nicotinic receptors using 10 µM galantamine did not alter the amount 
of cell death (52.83% ± 6.46, n=6). Similar levels of PI uptake in OHSCs were measured 
after treatment with 50 µM NMDA in combination with 50 mM choline alone (56.39% ± 
7.47, n=6) or with 10 µM galantamine (43.16% ± 4.69, n=6). 
Comparably, no significant effect of treatment was found in the CA1 (F5,29=1.028, 
p=0.420) or CA3 region (F5,13.158=2.422, p=0.092). Again, the highest levels of PI uptake 
were measured in the CA1 region, providing further evidence of this region’s 
susceptibility to NMDA-mediated excitotoxicity. Table 3-4 summarizes the mean PI 
uptake in DG, CA1, and CA3 for each of the treatment groups, as illustrated by Figure 
3-3.  
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Figure 3-3: Effects of co-activation of α7 nicotinic acetylcholine receptors and NMDA receptors in organotypic hippocampal slice cultures. Histograms show quantification of 
cell damage using propidium iodide (PI) in the three hippocampal regions dentate gyrus (DG), CA3 and CA1 after application of 50 µM NMDA (50N) either alone or in 
combination with saline (S), 10 mM choline (10C), 50 mM choline (50C), 10 mM choline and 10 µM galantamine (10G) and 50 mM choline and 10 µM galantamine. Data are 
shown as means ± SEM, with n = 5-6. One way ANOVA using Welch’s correction revealed no significant differences in any of the three hippocampal regions. 
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Table 3-4: Comparison of PI uptake after exposure to a high dose of NMDA in combination with α7 nicotinic 
receptor agonists in the dentate gyrus (DG), CA1 and CA3. Data are given as mean ± SEM.  
 DG CA1 CA3 
50 µM NMDA (50 N) 30.69% ± 5.87 52.99% ± 7.66 27.60% ± 5.20 
50 N + saline 38.99% ± 1.17 64.10% ± 3.76 40.59% ± 5.07 
50 N + 10 mM choline (10 C) 55.40% ± 9.30  73.29% ± 8.37 49.70% ± 9.78 
50 N + 50 mM choline (50 C) 56.39% ± 7.47 73.62% ± 11.77 62.81% ± 11.85 
50 N + 10 C + 10 µM 
galantamine (10 G) 
52.83% ± 6.46 69.88% ± 5.86 51.10% ± 5.65 
50 N + 50 C + 10 G 43.16% ± 4.69 66.06% ± 3.15 45.45% ± 4.53 
 
3.4 DISCUSSION 
This study was designed to investigate the effects of co-activation of α7 nicotinic 
acetylcholine receptors on NMDA-mediated cell damage in organotypic hippocampal 
slice cultures. Both receptor types have been shown to be expressed in OHSCs (Bahr et 
al, 1995; Mielke and Mealing, 2009; Prendergast et al, 2001b). Treatment with the 
specific α7 nAChR agonist choline alone or in combination with galantamine, an APL of 
the α7 nicotinic receptor, was employed at the same time as the excitotoxic insult with 
NMDA to investigate this experimental aim. Using PI as a marker of cell viability, it was 
of interest to determine if stimulation of α7 nAChRs alters NMDA-induced 
neurotoxicity. 
The results obtained show that administration of choline alone or in combination 
with the APL galantamine does not significantly change the level of NMDA-induced PI 
uptake. However, it is also clear that co-activation of α7 nicotinic receptors did not have a 
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neuroprotective effect. Rather, there seems to be a trend towards increased PI uptake and 
thus enhanced cell injury when α7 nAChRs and NMDARs are co-activated. Moreover, 
stimulation of α7 nAChRs alone, i.e. exposing OHSCs to choline in the absence of 
NMDA, significantly increased PI uptake in CA1 and DG as well as approached 
significance in CA3 when compared to saline-treated OHSCs. Exposure to galantamine 
alone appears to have no real effect on cell viability in OHSCs (Figure 3-1).  
Although this thesis was based mainly on the interaction between NMDARs and α7 
nAChRs, another role of the α7 nAChR in modulating the glutamatergic system could 
explain the observed results. As mentioned in section 1.5.2, the α7 nAChR can act both 
on presynaptic neurons and astrocytes to release Glu (Cheng and Yakel, 2014; Salamone 
et al, 2014). It is possible that this causes the increase in PI uptake seen in the saline 
control groups, where stimulation of α7 nAChRs with choline may induce the release of 
Glu resulting in activation of NMDA receptors and neurotoxicity. In OHSCs that were 
exposed to NMDA or DOM (see Appendix C), however, the α7 nAChR-mediated Glu 
release may be obscured, as this effect is small compared to the NMDA-mediated 
excitotoxicity. This hypothesis could be tested by administration of NMDA antagonists in 
the saline control groups to try and block the neurotoxic effect of choline. 
To activate α7 nAChRs in this test setting, slice cultures were exposed to choline, 
which has been shown to be a full and selective agonist of α7-containing receptors 
(Alkondon et al, 1997b; Papke et al, 1996). Choline also has the ability to act as a partial 
agonist at α9, α4β4, α3β4 (Do et al, 1986; Mandelzys et al, 1995; Pereira et al, 2002; 
Verbitsky et al, 2000; Zwart and Vijverberg, 2000) and as a co-agonist with ACh at α4β2 
nAChRs (Mulholland et al, 2004). However, Alkondon et al (1997a, 1997b, 1999) have 
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demonstrated that choline selectively activates α7 nAChRs in hippocampal neurons in 
either cultures or slices. Additionally, choline was administered in combination with 
galantamine, an APL of nicotinic receptors at low concentrations (Samochocki et al, 
2000; Schrattenholz et al, 1996), to potentiate the activity of α7 nicotinic receptors in the 
presence of choline. 
Nicotinic acetylcholine receptors, including α7 receptors, have been associated with 
signaling mechanisms mediating both neuroprotective and neurotoxic effects in various 
disease models and systems (Resende and Adhikari, 2009), although studies reporting 
neuroprotective actions prevail. For example, administration of nicotine can protect 
neurons against Aβ toxicity. This neuroprotective effect was blocked by the selective α7 
nicotinic receptor antagonist α-bungarotoxin, implying an important role for α7 nAChRs 
in neuroprotection against Aβ cytotoxicity (Kihara et al, 1997). A study by Arias et al 
(2005) further confirms neuroprotective effects linked to α7 receptors afforded by 
nicotine as well as AChE inhibitors including galantamine. Stimulation of α7 nAChRs 
may also protect neurons in certain models under various other pathological conditions, 
including oxidative stress (Cormier et al, 2003), trophic factor-deprivation (Martin et al, 
1994), and Glu-mediated excitotoxicity (Shimohama et al, 1998). Pre-treatment with 
dimethoxybenzylidene anabaseine, a α7 receptor agonist, proved to be neuroprotective 
against excitotoxicity in cultured neocortical neurons and against focal ischemic insults in 
rats. However, no neuroprotective effect was achieved when DMBX was administered 
concurrently with the insult (Shimohama et al, 1998). Similarly, preincubation with 
nicotine showed neuroprotective effects in acute hippocampal slices subjected to oxygen-
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glucose deprivation, whereas neuroprotection did not occur in slices prepared from α7 
nAChR knockout mice (Rosa et al, 2006).  
Despite the amount of evidence suggesting a neuroprotective role, the intracellular 
mechanism leading to α7 nAChR-mediated neuroprotection is still unclear. Some studies 
point towards an involvement of the PI3K-Akt pathway in the neuroprotective actions of 
galantamine and nicotine (Arias et al, 2005), which can then trigger an increase in 
expression of anti-apoptotic proteins such as BCL-2 (Kihara et al, 2001). Another 
possibility is the activation of the janus kinase 2 (JAK2)/Akt signaling pathway, which 
can induce overexpression of the antioxidant enzyme heme oxygenase-1 (Parada et al, 
2010).  
While many studies report the neuroprotective effects of α7 nAChR-activity, some 
studies have linked α7 nAChRs to neurotoxicity. It has been suggested that over-
activation of this receptor subtype may be neurotoxic (Li et al, 1999) – similar to 
NMDA-mediated excitotoxic effects. For example, a mutated form of this receptor that 
does not desensitize is associated with reduced neuronal cell viability in C. elegans, 
possibly due to calcium overload (Treinin and Chalfie, 1995). However, observations by 
Li et al (1999) indicate that normal α7 nAChRs can also induce cell death following 
acute application of high concentrations of nicotinic agonists in vitro. Furthermore, α7 
receptors can induce distinct intracellular transduction processes in PC12 cells, 
depending on the level of activation. More specifically, the activation of protein kinase C 
seems to be neuroprotective, whereas cell death is dependent on tyrosine protein kinase 
(Li et al, 1999). 
88 
 
The results of this experiment provide further support for the potential neurotoxic 
effects of α7 nicotinic receptor-mediated signaling. A possible explanation for the 
discrepancy in the literature is that neuroprotection and neurotoxicity may depend on 
developmental changes in receptor expression. Laudenbach et al (2002) demonstrated 
that activation of α7 nAChRs, although protective in adult animals, induces neuronal 
death in a neonatal murine model of glutamatergic injury occurring between PND5 and 
PND10. The authors propose that this neurotoxic effect may be due to overexpression of 
α7 nicotinic receptors in the early postnatal stage. Supporting this notion, Broide et al 
(1996) demonstrated that the expression of α7 nAChR mRNA and receptor binding sites 
within the rat cortex was shown to peak during the first postnatal week and then 
decreased to adult levels. 
However, this maturation theory may not be sufficient to explain the inconsistencies 
with the results in this thesis for several reasons. For one, additional experiments using 
primary cultures of embryonic cortical neurons in the same study by Laudenbach et al 
(2002) provide evidence that α7 receptor stimulation is neuroprotective, although the 
authors suggest differences in neuron maturation and density of α7 nAChR-mediated 
calcium influxes due to a lack of astroglial cells in neuron cultures as a potential 
explanation for this inconsistency in their own study.  
Similar to what is observed  in the cortex in vivo (Broide et al, 1996), α7 nAChRs 
expression increases with time in OHSCs, reaching the peak at DIV14 and decreasing 
thereafter (Mielke and Mealing, 2009). However, the majority of α7 subunits were 
located internally, with only about 11% being present at the surface. Furthermore, an 
ultrastructural study revealed an abundance and near-ubiquitous expression of α7 
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receptors at hippocampal synapses in adult rats (Fabian-Fine et al, 2001). These reports 
suggest that differences in receptor expression between neonatal and adult neurons may 
not be the reason for the opposing effects of α7 nAChR activation. 
The theory of developmental differences in receptor expression also seems 
unsatisfactory as several other studies with similar experimental design to this thesis have 
reported neuroprotective effects of stimulation of α7 nicotinic receptors (Egea et al, 2007; 
Mulholland et al, 2004; Prendergast et al, 2001a). These studies provide evidence that 
both nicotine and choline can enhance neuroprotection against NMDA-mediated 
excitotoxicity as well as oxygen-glucose deprivation in acute and organotypic 
hippocampal slice cultures prepared from Sprague-Dawley rats of different ages (PND8 
and adults) at different times in culture (DIV8 and DIV25). The involvement of α7 
nicotinic receptors was demonstrated in two of these studies by application of the specific 
α7 nAChR antagonist methyllycaconitine (Mulholland et al, 2004) or by the use of α7 
nicotinic receptor knockout mice (Egea et al, 2007). Due to the use of the non-selective 
nicotinic receptor antagonist mecamylamine in the study by Prendergast et al (2001a), the 
possible involvement of other nicotinic receptor subtypes, such as the α4β2, cannot be 
dismissed.  
The experimental protocol in the studies mentioned above encompassed a period of 
pre-treatment of the cultures with the respective nicotinic receptor agonist followed by 
exposure to the stressor in combination with the same nAChR agonist. The pre-treatment 
period ranged from 30 minutes (Egea et al, 2007) up to 3 days (Mulholland et al, 2004) 
and even 5 days (Prendergast et al, 2001a). It is possible that the pre-exposure to 
nicotinic agonists induces transcriptional and translational intracellular processes, such as 
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activation of JAK2/STAT3 pathway or the PI3K/Akt pathway (Kawamata and 
Shimohama, 2011), to increase neuronal survival. With regards to a direct interaction 
between NMDA receptors and α7 nicotinic receptors, Li et al (2013) hypothesize that the 
α7 nAchR-dependent calcium influx may trigger intracellular signaling pathways that 
lead to changes in NMDAR function via altered phosphorylation, conformational 
changes, or altered surface expression. 
Nevertheless, several studies indicate that the neuroprotective effects of α7 nicotinic 
receptors are not dependent on pre-exposure to specific agonists. Indeed, the presence of 
galantamine during oxygen-glucose deprivation and reoxygenation was able to increase 
cell viability (Egea et al, 2012). Additional experiments in the same study indicated that 
this neuroprotective effect was not mediated by AChE inhibition, but rather due to 
activation of α7 nAChRs. The selective α7 nAChR agonist PNU282987 also elicited 
neuroprotection against subchronic oxidative stress in OHSCs, when applied concurrently 
to the insult (Navarro et al, 2015). In the human neuroblastoma cell line SH-SY5Y, 
PNU282987 can protect against apoptotic cell death, even if added after an 8 hour stress 
period (Parada et al, 2010). Furthermore, using a similar experimental design to this 
thesis, Prendergast et al (2001b) demonstrated that acute nicotine exposure increases 
neuronal survival after exposure to NMDA. The α7 nAChR was linked to this 
neuroprotective effect, as the α7 nAChR antagonist methyllycaconitine mitigated the 
protective action. Therefore, activation of the α7 nAChR appears to be able to promote 
neuronal survival regardless of whether agonists are applied before, during or after an 
insult.  
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Results of this study indicating potential neurotoxic properties of α7 nAChR 
stimulation are supported by a recent publication demonstrating that positive allosteric 
modulation of α7 nAChR can induce cytotoxicity in SH-SY5Y cells, but also in OHSCs  
(Guerra-Álvarez et al, 2015). The authors propose that this is due to sustained opening of 
the α7 receptor channel and thus receptor over-activation in the presence of the type II 
positive allosteric modulator PNU120596. Uteshev (2016) points out that the 
concentrations and exposure durations chosen by Guerra-Álvarez et al (2015) are not 
clinically relevant and the study seems to purposely target excessive levels of α7 nAChR 
activation. Although two previous publications confirm the cytotoxic potential of 
excessive α7 nAChR activation by PNU120596 (Ng et al, 2007; Williams et al, 2012), no 
cytotoxicity was detected at lower ranges, and in fact a trend for increased cell viability 
was noticeable in these studies. 
With regards to this study, it seems unlikely that the neurotoxic effects elicited by the 
chosen concentrations of choline (10 mM and 50 mM) (see Figure 3-1) are due to 
excessive activation of  α7 nAChRs, as 10 mM choline were shown to be protective 
against NMDA-induced toxicity in OHSC if applied before the excitotoxic insult 
(Ferchmin et al, 2003; Mulholland et al, 2004). However, as some studies suggest that 
high doses of agonists may induce prolonged desensitization of nicotinic receptors, thus 
causing inhibition of the receptor (Laudenbach et al, 2002), additional experiments with 
lower choline concentrations may provide further insights into potential mechanisms of  
cytotoxicity relating to α7 nicotinic receptors. Addition of 10 µM galantamine did not 
affect cell damage in OHSCs at all and did not seem to potentiate choline-mediated 
activity. Experiments in the human embryonal kidney cell line HEK-293 indicate 
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inhibitory actions of galantamine at concentrations higher than 10 µM (Samochocki et al, 
2003). Therefore, lower concentrations should be tested in future experiments. However, 
it should be noted that neuroprotective effects of 10 µM galantamine have previously 
been shown to involve α7 nAChR activation and not AChE inhibition (Egea et al, 2012),  
In summary, results obtained from the present experiment provide no evidence of a 
neuroprotective role of α7 nicotinic receptor activation against NMDA-mediated 
excitotoxicity in organotypic hippocampal slice cultures. In contrast, some trends toward 
increased cell death after application of the α7 nAChR agonist choline were detected. 
Nonetheless, given the small sample size per treatment group as well as the variability 
observed, further investigation – especially with lower concentrations of choline - is 
required to draw more firm conclusions from the observations described. 
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CHAPTER 4:  
OVERALL CONCLUSIONS AND FUTURE DIRECTIONS 
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4.1 CONCLUSIONS  
The aim of this thesis was threefold: First, to develop a method that allows objective 
quantification of cell death in organotypic hippocampal slice cultures using propidium 
iodide. The second aim was to establish a dose-response curve for NMDA toxicity. Based 
on these two aims, the effects of co-activation of α7 nicotinic receptors on NMDA-
induced cell death in OHSCs could be determined 
In order to achieve the first two aims, slice cultures were prepared from rats at 
PND5/6 according to the interface method and exposed to different concentrations of 
NMDA on day 13 in vitro. PI uptake was measured by separation of the hippocampal 
subfields using simple landmarks and densitometric quantification of fluorescence 
intensity in 10 template-oriented counting fields. This protocol facilitates the objective 
and quantitative analysis of cell death in distinct regions of organotypic hippocampal 
slice cultures in a standardized format, allowing for analysis and comparison of the 
effects of drug exposure on cell viability in this preparation. The results of these 
experiments show that exposure to increasing concentrations of NMDA result in a dose-
dependent increase in PI uptake and thus cell death in organotypic hippocampal slice 
cultures; an effect evident in all hippocampal subfields. Similar to previous literature, a 
region-specific vulnerability to NMDA-mediated insults was demonstrated, with the CA1 
region being the most sensitive. 
The PI uptake induced by NMDA in this thesis is lower compared to published 
reports using similar measures of NMDA-mediated PI uptake in OHSCs. As discussed in 
Chapter 2, this discrepancy is likely due to variations in the method used to induce 
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maximal cell death. Future experiments could induce maximal cell death by using high 
concentrations of Glu to provide evidence for this theory. 
The α7 nAChR may play multiple roles with regards to the glutamatergic system, as 
this receptor type can modulate Glu transmission and therefore NMDA receptor activity 
by different ways depending on the α7 nAChR location. For example, activation of 
presynaptic α7 nAChR can facilitate the release of GABA (Arnaiz-Cot et al, 2008), 
which may modulate excitatory neurotransmission and potentially even NMDA receptor 
calcium signals (Chalifoux and Carter, 2010), as well as Glu (Gray et al, 1996) from 
presynaptic terminals,. The experiments of this thesis focused on investigating the 
interaction of α7 nAChRs and NMDARs at postsynaptic locations, where α7 nAChRs 
can modulate the activity of NMDA receptors (Fisher and Dani, 2000). 
Using the quantification protocol of PI uptake developed in Chapter 2, the effects of 
co-activation of α7 nicotinic receptors on NMDA-induced cell death in OHSCs were 
investigated by treating slice cultures with NMDA in combination with choline, a 
specific α7 nAChR agonist, and the APL galantamine. While co-activation of α7 nAChRs 
did not significantly alter NMDA-induced PI uptake in any of the hippocampal regions, 
stimulation of α7 nAChRs alone in the absence of NMDA resulted in increased cell 
damage in some hippocampal regions. Taken together, these results imply a role for α7 
nAChRs on presynaptic neurons and astrocytes rather than postsynaptic α7 nAChRs. In 
the saline control groups, administration of choline may activate α7 nAChRs on the 
presynapse or on astrocytes causing the sudden release of Glu and subsequent activation 
of postsynaptic NMDA receptors, which subsequently causes neurotoxicity. In contrast, 
slice cultures that are exposed to NMDA already experience an excitotoxic insult, which 
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results in increased PI uptake. Compared to cell injury induced by NMDA, the effect of 
α7 nAChR-mediated Glu release is small and may be obscured in OHSCs exposed to a 
combination of NMDA and choline. Thus, co-activation of α7 nAChRs in these slice 
cultures does not affect PI uptake and cell viability. To investigate this possibility, it is 
necessary to assess the effect of NMDAR antagonists on choline-induced neurotoxicity. 
If the neurotoxic effects are due to α7 nAChRs-mediated Glu release from presynaptic 
terminals or astrocytes, NMDAR antagonists should prevent the increase of PI uptake. 
 
4.2 FUTURE DIRECTIONS 
As highlighted in section 3.4, other authors have seen neuroprotective actions of α7 
nAChR stimulation using the same and lower doses of choline. Future investigations 
should therefore investigate the effect of lower concentrations of choline and galantamine 
on NMDA-mediated excitotoxic cell death in order to rule out the possibility that 
neurotoxic effects seen in these experiments are due to excessive activation of α7 
nAChRs. Furthermore, the involvement of α7 nAChR should be conclusively assessed 
using specific antagonists. 
Although NMDA receptors and α7 nicotinic receptors in physiological and 
pathophysiological events are known to functionally interact, the exact mechanisms 
underlying neuroprotective or neurotoxic effects of α7 nAChR activation in NMDA-
mediated excitotoxicity are still unclear. It is possible that co-activation of α7 nAChRs 
can influence the switch of NMDAR signaling from a pro-death to a pro-survival 
pathway or vice versa. Thus, the determination of how α7 nAChR stimulation may 
influence the expression of proteins in this signaling cascade would be of interest.  
97 
 
However, the choline-induced neurotoxic effects seen in the saline control slice 
cultures may suggest the involvement α7 nAChR-mediated Glu release. This alternative 
explanation should be investigated in future experiments using specific NMDAR 
antagonists. 
Furthermore, the use of young animals in stroke research is often criticized and the 
need to prepare organotypic slice cultures from adult donors has been voiced (Humpel, 
2015b). With reports showing developmental differences in receptor expression, it would 
be useful to investigate the interaction of α7 nicotinic receptors and NMDA receptors in 
slice cultures prepared from older rats. Although there are still various challenges to 
overcome, including the long-term maintenance of adult organotypic slices, the 
implementation of this factor is an important step towards an experimental setting that is 
more representative of an in vivo population. 
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APPENDIX A: DEVELOPMENT OF THE QUANTIFICATION PROTOCOL — 
EFFECTS OF CULTURE MEDIA  
 
OBJECTIVE 
In order to establish a dose-response relationship between NMDA exposure and cell 
death in OHSCs, an initial set of experiments was modeled after a publication by 
Kristensen et al (2001). In this study, the authors compared the excitotoxic profiles of 
several GluR agonists, including NMDA, in OHSCs.  
In these initial experiments, OHSCs were prepared as described in Chapter 2 and 
incubated in MEM-based culture medium. As the magnesium concentration in this type 
of medium is quite high and Mg
2+
 has the ability to block the channel pore of the NMDA 
receptor (see Chapter 1, Section 1.3), the cultures were switched after four days of 
incubation to a Neurobasal® based culture medium, which has a lower concentration of 
Mg
2+
, to limit any influence the high Mg
2+
 levels may have on the experiments.  
METHODS 
Similar to the methods described in Chapter 2, the viability of the slice cultures was 
assessed by PI uptake on DIV13 and OHSCs with low basal levels of PI uptake were 
exposed to different concentrations of NMDA for 4 hours followed by 24 hours in fresh 
Neurobasal® culture medium. The PI uptake was measured again, and the slices were 
exposed to phosphate buffered saline (PBS) at 4°C for another 24 hours to induce 
maximal cell death. A final set of PI uptake was taken on DIV15 representing the 
maximal PI uptake. 
99 
 
The digital pictures of PI uptake were analyzed by densitometry with ImageJ 
inspired by NIH Image. As the hippocampal structure of these slice cultures were 
generally not visible in light microscope pictures or in OHSCs with lower PI uptake, 
quantification of PI uptake in the distinct hippocampal subregions was not possible. 
However, the irregular shape and size of the hippocampal slices renders the analysis of 
fluorescence intensity over the whole slice and comparison of slice cultures to each other 
inaccurate. As a compromise of these two methods, a standard template of 50 circles 
throughout the picture was used, the placement of which was fixed (see Figure A-1). Two 
background circles were used for subtraction of any background noise. The raw 
integrated density, the sum of the pixel values, was calculated for every circle of each 
slice. Density measurements of OHSCs after induction of maximal cell death were used 
to establish a threshold value for each individual slice, defined as 30% of the maximum 
raw integrated density measured for this slice. If the density of a circle was higher than 
the threshold value, it was considered positive and counted as 1, and if it was lower it was 
considered negative and given a 0. The ratio of the circles over the threshold value after 
the drug treatment and the amount of circles over the threshold after the low-temperature 
exposure to PBS was calculated, and in this way the PI uptake could be expressed in 
percentage of the maximal PI uptake.  
RESULTS 
Using this method, control slice cultures treated with saline showed an average PI uptake 
of 4.41% ± 2.17 (n = 6). However, the PI uptake plateaued at 31.91% ± 9.99 after 
exposure to 500 µM NMDA (n = 6). To validate these results, two additional methods, a  
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Figure A-1: Standard template to facilitate quantification of propidium iodide. Representative illustration 
shows placement of measurement windows in the hippocampal areas (dentate gyrus, CA3 and CA1) of 
propidium iodide-stained organotypic hippocampal slice cultures grown in Neurobasal media®. 
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lactate dehydrogenase cytotoxicity assay (Abcam, ab65393) and Fluoro-Jade C (FJC) 
staining (see Appendix B) were tested. The LDH assay was unsuccessful as no LDH 
could be detected in collected media samples. As preparation for Fluoro-Jade C staining, 
OHSCs were fixed in 10% formalin, frozen in cryomatrix and sliced using a cryostat 
following a previously established protocol from our laboratory (Pérez-Gómez and 
Tasker, 2012).  
However, slicing of the cultures was unsuccessful as the tissue was generally 
undetectable. As the only difference to the methods by Pérez-Gómez and Tasker (2012) 
was the type of media used (MEM vs Neurobasal®-based), and Neurobasal® culture 
media has been shown to induce toxicity in hippocampal cell culture (Hogins et al, 2011), 
a small experiment was conducted looking at the effects of different culture media on 
viability of OHSCs. Slice cultures were prepared as before, but either kept in MEM-
based culture medium until DIV13 or switched to the Neurobasal®-based medium at 
different time points (on DIV4, on DIV11, or on DIV13 2 hours before the exposure). 
Cultures that were grown in MEM-based medium showed no or only a low basal PI 
response on DIV13, whereas cultures that were switched to Neurobasal® medium on 
DIV4 showed a medium to high amount of PI uptake. OHSCs switched to the 
Neurobasal® medium on DIV11 or two hours before PI exposure showed low to medium 
PI uptake (data not shown). This suggests that the Neurobasal® medium induces higher 
rates of spontaneous cell death compared to MEM-based culture medium, potentially 
mediated by high concentrations of L-cysteine (Hogins et al, 2011). 
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CONCLUSIONS 
For further experiments, OHSCs were exclusively grown in MEM-based culture 
medium. Additionally, omitting the switch to Neurobasal® medium also seemed to have 
an effect on the growth of the cultures, as the delineation of hippocampal subfields CA1, 
CA3 and the DG was possible using light microscope pictures in addition to PI images, 
when cultures were grown in the MEM-based culture medium. This offered the 
opportunity to develop a method of measuring fluorescence intensity in individual 
regions (see Section 2.2.5 Image analysis and quantification of PI fluorescence), which 
provided more accurate results. The higher concentration of Mg
2+
 in this media did not 
appear to affect NMDA-mediated toxicity, as levels of PI uptake as high as 59.30% ± 
3.91 were measured in the CA1 region of the hippocampus after exposure to 1000 µM 
NMDA.  
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APPENDIX B: VALIDATION OF THE CELL DEATH QUANTIFICATION 
METHOD IN ORGANOTYPIC HIPPOCAMPAL SLICE CULTURES 
 
OBJECTIVE 
The analysis of cellular uptake of propidium iodide is commonly used in the 
literature to quantify neuronal cell death in organotypic hippocampal slice cultures and PI 
has been shown to be a reliable marker, but some doubts about the sole use of PI uptake 
have been raised (Noraberg et al, 1999). Several other markers of neurodegeneration 
have been tested in OHSCs, including lactate dehydrogenase and Fluoro-Jade staining.  
The LDH cytotoxicity assay is a commonly used marker in cytotoxicity studies and 
has been used in organotypic hippocampal slice cultures in previous literature (Bruce et 
al, 1995; Fotakis and Timbrell, 2006; Noraberg et al, 1999). The assay is based on the 
measurement of LDH activity in the extracellular medium. LDH is a stable enzyme, 
present in all cell types, and rapidly released into the cell culture medium upon damage of 
the plasma membrane. LDH can oxidize lactate to generate NADH, which then reacts 
with the cell proliferation reagent water soluble tetrazolium-1 (WST-1) to produce a 
yellow color. The intensity of this yellow color correlates directly with the number of 
lysed cells (Egea et al, 2007; Noraberg et al, 1999). To investigate this assay for 
validation of PI uptake, several samples of collected culture media and homogenized 
OHSC tissue were tested in the current study according to the instructions from the 
manufacturer (Abcam, ab65393) and previously published protocols (Noraberg et al, 
1999; Su et al, 2011). Samples were collected after exposure to 100 µM NMDA, 500 µM 
NMDA, or PBS or ethanol at low temperature to serve as a positive control. 
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Unfortunately, no LDH activity was detected and implementation of this cytotoxicity 
assay proved unsuccessful. The exact reasons for why this assay may have failed are 
unclear. However, it is possible that the amount of LDH released through the semiporous 
membrane insert was too diluted by the 1 ml of media in the culture dish. 
Thus, a staining method using the fluorochrome dye Fluoro-Jade C (Millipore) was 
performed to validate the quantification method described in Chapter 2 using PI uptake. 
FJC stains all degenerating neurons, regardless of specific insult or mechanism of cell 
death, and it has a greater signal to background ratio and higher resolution compared to 
its predecessors, Fluoro-Jade and Fluoro-Jade B (Schmued et al, 2005). Additionally, this 
type of staining has the advantage that double-labeling with other fluorescent markers is 
possible, such as 4’, 6-diamidino-2-phenylindole (DAPI), which labels nuclear DNA. The 
staining protocol was adapted from previously published protocols (Eyüpoglu et al, 2003; 
Noraberg et al, 1999; Schmued et al, 2005). 
METHODS 
Preparation of organotypic hippocampal slice cultures, maintenance, and exposure 
procedures were as reported in Chapter 2 and Chapter 3 of this thesis. On day 13 in vitro, 
healthy OHSCs, as determined by low PI uptake, were exposed to different 
concentrations of NMDA (Sigma-Aldrich) (1 µM, 10 µM, 50 µM, 100 µM, 500 µM, and 
1 mM) in 0.9% saline, or to 0.9% saline alone as control for 4 hours. Slice cultures were 
then transferred to fresh culture medium for 24 hours, after which PI uptake was 
measured. To serve as positive controls, OHSC were exposed to ice cold 70% ethanol for 
24 hours at -20°C.  
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Fluoro-Jade C staining 
After slice cultures were exposed to their respective treatments and microscope 
pictures of PI uptake were taken, slices were prepared for formalin fixation. OHSC were 
washed 3 times with 1x PBS at room temperature by transferring the inserts with the 
slices from one dish filled with PBS to the next. The same process was repeated using 
10% neutral buffered formalin. After the washes, extra formalin was added to the top of 
the insert covering the slices. The slices were then left in the final formalin wash for 5 
hours at 4°C. The inserts with slices were then washed again with 1x PBS and transferred 
to a dish containing 1 ml of 1x PBS + 0.1% Triton X solution. This solution acts as a 
permeabilization buffer to enhance penetration of the dye. The slices were then covered 
with extra buffer solution, and kept at 4°C overnight. If slices were not used immediately, 
they were transferred to 1x PBS and kept at 4°C until further processing, but not longer 
than 2 weeks. 
The slice cultures were kept on the inserts for the staining procedure, and solutions 
were, therefore, always added to the staining dish and on top of the inserts to cover the 
slices completely. Slices were washed for 3 min in 100% ethanol for 3 min, for 1 min in 
75% ethanol and 1 min in ddH2O, and then incubated in 0.06 potassium permanganate 
(Sigma) solution for 15 min. Slices were washed again in ddH2O for 1 min, and then 
transferred to 0.0001% Fluoro-Jade C (Millipore) in 0.1% acetic acid solution for 60 min. 
OHSC were washed in ddH2O 3 times for 3 min each, and then transferred to a 1:500 
dilution of DAPI (Sigma), a nuclear counterstain, for 15 min. Slices were rinsed through 
three changes of ddH2O for 3 min per change, and then cut out on pieces of membrane 
and gently placed onto  microscope slides coated with 0.5% gelatin, with the membrane 
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on the bottom. The slides with slice cultures were air dried, cleared in xylene for at least 
1 min and then coverslipped with PermaFluor mounting media (Thermo Fisher 
Scientific).  
Image analysis and quantification of FJC staining 
The FJC stained sections were examined using a LSM 710 laser scanning confocal 
microscope (Zeiss, Germany) with a fluorescein isothiocynate (FITC) filter system. To 
ensure comparability, the following optimal settings for FJC (see Table B-1) were chosen 
after an initial trial run and always kept the same. DAPI stained cells were visualized 
using a specific DAPI filter. DAPI staining was not quantified, as it was only auxiliary to 
determine hippocampal structures. Because of the varying thickness of slice cultures, the 
focal plane was chosen according to where the highest FJC intensity was detected. 
Images were taken using the tile scan option. 
Table B-1: Laser confocal microscope settings for Fluoro-Jade C quantification.  
Dimensions x: 5120, y: 5120, 8-bit 
Objective Plan-Apochromat 20x/0.8 M27 
Pixel dwell 0.64 µs 
Average 1 
Master gain 764 
Digital gain 1.00 
Digital offset -31.79 
Pinhole 61 µm 
Lasers 488 nm: 0.2559% 
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RESULTS 
Figure B-1 shows a representative picture of a slice culture exposed to 100 µM 
NMDA and subsequently stained with DAPI and Fluoro-Jade C. FJC intensity was 
intended to be quantified similarly to the quantification method used for the PI staining  
(see Chapter 2). Table B-2 summarizes the results of the initial analysis of slice cultures 
exposed to saline, 50 µM, 100 µM, and 500 µM NMDA obtained using ImageJ, as 
described in Section 2.2.3 of Chapter 2. The average intensity measured in slice cultures 
exposed to 70% ethanol at low temperature was set as the maximum (n=5). Figure B-2 
shows representative pictures of slice cultures exposed to different concentrations of 
NMDA. 
Table B-2: Comparison of Fluoro-Jade C uptake (as percent of maximum) after exposure to increasing 
concentrations of NMDA in the dentate gyrus (DG), CA1 and CA3. Data are given as mean ± SEM. 
 n DG CA1 CA3 
saline 5 25.81 14.12 21.65 
50 µM NMDA 6 58.08 64.12 58.60 
100 µM NMDA 6 43.56 43.78 51.39 
500 µM NMDA 6 58.73 57.65 58.25 
 
CONCLUSION 
The results show clear differences between saline treated slice cultures, positive 
control OHSCs and slice cultures exposed to NMDA. However, the FJC staining did not 
appear to discriminate the effects of increasing NMDA concentrations as well as PI 
uptake (compare Table B-2 and Figure B-2). The values for FJ intensity are generally 
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Figure B-1: Representative image of a hippocampal slice culture exposed to 100 µM NMDA and double-labelled with the nuclear stain DAPI (left in blue) and 
Fluoro-Jade C (green), a marker of neuronal degeneration 
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Figure B-2: Representative images of Fluoro-Jade C uptake in organotypic hippocampal slice cultures following 4 h exposure to saline, 1 µM NMDA, 50 
µM NMDA, 100 µM NMDA and 500 µM  NMDA as measured after 24 h in fresh culture media as well as a slice culture exposed to 70% ethanol at 4°C 
for 24 h to obtain the maximal possible Fluoro-Jade C uptake. 
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higher, as even control slice cultures show an uptake of approximately 20%. This is most 
likely artificially created by the chosen exposure settings.  
It is interesting to note that, similar to PI uptake, FJC intensity appears to plateau 
around 60-65% of the maximum possible value, agreeing with the data obtained using PI.  
During these experiments, several problems with this staining method became 
apparent. Firstly, the staining procedure caused cracks in many slice cultures. This is 
most likely attributable to the dehydration steps. Additionally, the hippocampal structures 
were not consistently visible in the DAPI-stained images which made correct placement 
of the counting fields difficult. The staining procedure and recording of fluorescence 
imaging using the laser scanning confocal microscope are also very time consuming. As 
the FJC staining did not provide any additional information, it was decided that analysis 
of cell death using PI uptake alone would suffice.   
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APPENDIX C: EFFECT OF DEPOLARIZATION USING DOMOIC ACID ON 
NMDA RECEPTOR-MEDIATED EXCITOTOXICITY IN ORGANOTYPIC 
HIPPOCAMPAL SLICE CULTURES 
 
OBJECTIVE 
Initial experiments to construct a dose-response curve and quantify cell death using 
PI revealed less cell death than expected from the literature. For example, data obtained 
in the experiments described in this thesis show that administration of 100 µM NMDA 
results in PI uptake of approximately 30% of the maximum possible cell death (as 
measured after low temperature exposure to 70% ethanol), whereas several publications 
report PI levels of 80-100% after exposure to 100 µM NMDA (Kristensen et al, 2001; 
Sakaguchi et al, 1997). Although differences in methodology of PI quantification account 
for some of these seemingly contrary results (see Chapter 2 Section 2.4.2 for detailed 
discussion), additional experiments were performed to test an alternative idea.  
As mentioned in Chapter 1, extracellular Mg
2+
 blocks the channel pore of the 
NMDA receptor at resting potential. Upon membrane depolarization, the Mg
2+
 block is 
removed and ions can enter the cell through the NMDAR channel. Therefore, the 
activation of NMDA receptors does not only rely on agonist binding, but also exhibits a 
voltage-dependence. Moderate local depolarization can be achieved by activation of 
ionotropic AMPA/kainate receptors, for example, which results in Na
+
 influx.  
Domoic acid (DOM) is a naturally occurring Glu analogue found in seaweed and 
plankton (Costa et al, 2010). DOM can elicit a potent excitotoxic response as an agonist 
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of AMPA and kainate receptors, although some evidence suggests an involvement of 
NMDA receptors as well (Tasker et al, 2005).  
 Previous studies in our laboratory have shown that low concentrations of DOM can 
induce mild excitotoxic injury in organotypic hippocampal slice cultures. Concentrations 
≥1 µM DOM produced significantly increased PI uptake in the CA1 subfield of the 
hippocampus, whereas exposure concentrations of ≥5 µM DOM were necessary to 
induce significant toxicity within the DG and CA3 region (Pérez-Gómez and Tasker, 
2012).  
The objective of this experiment was to examine whether depolarization using a low 
dose of DOM can increase cell damage induced by 100 µM NMDA in OHSCs. 
METHODS 
Preparation of organotypic hippocampal slice cultures, exposure procedures and 
quantification of PI uptake were as reported in Chapter 2 and Chapter 3 of this thesis.  
On day 13 in vitro, healthy OHSC, as determined by low PI uptake, were exposed to 
different combinations of 2 µM DOM, 100 µM NMDA, choline (50 mM or 100 mM) and 
10 µM galantamine for 4 hours. Slice cultures were then transferred to fresh culture 
media for 24 hours, after which PI uptake was measured again to determine the effects of 
drug exposure on cell viability. The data for the exposure condition of 100 µM NMDA as 
well as for the positive controls (exposed to ice cold 70% ethanol for 24 hours at -20°C) 
were used from Chapter 2. PI uptake was quantified by densitometry using the standard 
template of 10 movable, circular regions of interest, with three in each of the 
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hippocampal regions as described in Chapter 2, Section 2.2.5. PI uptake induced by the 
different treatment conditions was expressed as the percentage of the maximal PI uptake. 
All densitometric data were expressed as mean ± SEM. Data of the three 
hippocampal regions, DG, CA1, and CA3, were analyzed separately using one way 
ANOVA followed by Tukey’s post-hoc test or Welch’s ANOVA followed by Games-
Howell procedure where appropriate. Statistical analyses were performed using SPSS 
Statistics Version 23 (IBM Corporation, NY, USA) at a level of significance of 0.05.  
RESULTS 
As shown in Chapter 2, differences in susceptibility to NMDA-induced toxicity exist 
between the three hippocampal regions. Therefore, results were analyzed for each region 
individually. 
Dentate gyrus 
Normality of the data was confirmed using the Kolmogorov-Smirnov test (p>0.05). 
Levene’s test of homogeneity of variances was significant (p=0.026). Thus, Welch’s F-
ratio was used to assess significance between groups. A significant difference between 
groups was found using Welch’s ANOVA (F8,19.865=4.886, p=0.002). The Games-Howell 
procedure was therefore performed to compare the different treatment groups 
Slice cultures exposed to 2 µM DOM alone showed a PI uptake of 27.00% ± 2.87 
(n=7) (see Figure C-1). Addition of 50 mM choline did not alter the cell damage in  
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Figure C-1: Histograms show quantification of cell damage using propidium iodide (PI) in the dentate gyrus 
(DG) of organotypic hippocampal slice cultures. Slice cultures were exposed to different combinations of drugs 
(100 µM NMDA (100N), 2 µM domoic acid (D), 10 mM choline (10C), 50 mM choline (50C) or 100 mM choline 
(100C) and 10 µM galantamine (10G)) for 4 hours. PI uptake was measured after 24 hours in fresh media. Data 
are shown as means ± SEM, with n = 5–9. One way ANOVA using Welch’s correction followed by Games-
Howell post-hoc test revealed significant differences, *p<0.05 from D + 100N +10C + 10G. 
 
  
* * * * 
* 
* 
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OHSC (27.72% ± 3.46, n=7, p=1.00). In slice cultures exposed to 2 µM DOM in 
combination with 100 μM NMDA, a PI uptake of 40.76% ± 4.84 (n=9) was measured, 
which was not significantly different from any other group. 
The highest PI levels of 51.12% ± 3.46 were measured in slice cultures treated with 2 
µM DOM, 100 µM NMDA, 10 mM choline and 10 µM galantamine (n=5). This value 
was significantly different from all other treatment conditions, except for OHSCs 
exposed to 2 µM DOM with 100 µM NMDA (40.76 ± 4.84, n=9, p=0.714) or 2 µM 
DOM, 100 µM NMDA and 10 µM galantamine (46.76 ± 6.55, n=6, p=0.999). Table C-1 
summarizes the values for PI uptake for the other treatment groups.  
CA1 
Normality of the data was confirmed using the Kolmogorov-Smirnov test (p>0.05). 
Analysis of the data using Levene’s test for homogeneity of variances revealed 
significance (p<0.0005). Consequently, Welch’s ANOVA was used to assess differences 
between groups and a significant difference was found (F8,19.899=5.719, p=0.001). Post-
hoc tests were performed using Games-Howell procedure. 
Similar to previous experiments (see Chapter 2 and Chapter 3), the highest values in 
each treatment group were generally measured in the CA1 region, followed by the DG 
and CA3 (see Table C-1 for a summary of all the values). For example, OHSCs treated 
with 2 µM DOM showed a PI uptake of 46.73% ± 4.43 in CA1 vs 26.30% ± 2.87 and 
23.57% ± 1.85 in DG and CA3 (n=7), respectively. 
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Table C-1: Propidium iodide uptake in the dentate gyrus (DG) and CA3 and CA1 hippocampal regions in organotypic slice cultures treated with different 
combinations of 2 µM DOM, 100 µM NMDA, choline (50 mM or 100 mM) and 10 µM galantamine for 4 hours, as recorded after 24 h in fresh media. Data 
expressed as percentage of positive control exposed to 70% ethanol at low temperature for 24 h (mean ± SEM). *p<0.05 vs D + 100 N + 10 C + 10 G in each 
region. 
Treatment conditions n DG CA1 CA3 
2 µM DOM (D) 7 26.30 ± 2.87* 46.73 ± 4.43* 23.57 ± 1.85* 
D + 50 mM choline (50 C) 7 (6 for CA3) 27.72 ± 3.46* 59.09 ± 5.20 27.54 ± 1.56 
D + 100 µM NMDA (100 N) 9 40.76 ± 4.84 62.13 ± 6.06 34.85 ± 1.73 
D + 100 N + 10 µM galantamine (10 G) 6 46.76 ± 6.55 73.49 ± 8.45 36.72 ± 3.27 
D + 100 N + 50 C 8 29.08 ± 1.93* 43.05 ± 2.19* 26.24 ± 2.30* 
D + 100 N + 100 mM choline 8 30.73 ± 1.62* 46.70 ± 3.05* 29.76 ± 3.16 
D + 100 N + 10 C + 10 G 5 51.12 ± 3.46 74.03 ± 4.43 41.08 ± 4.45 
D + 100 N + 50 C + 10 G 5 26.74 ± 3.93* 49.11 ± 4.39 24.65 ± 1.42* 
100 µM NMDA 6 30.40 ± 3.41* 57.33 ± 9.45 27.62 ± 3.36 
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As in the DG, addition of 50 mM choline did not significantly alter PI incorporation 
(59.09% ± 5.20, n=7, p=0.677). When compared to slice cultures treated with 100 µM 
NMDA alone (57.33% ± 9.45, n=6), inducing neuronal depolarization with 2 µM DOM 
in addition to 100 µM NMDA does not significantly increase cell death (62.13% ± 6.06, 
n=9, p=1.000). Furthermore, co-activation of α7 nicotinic receptors using choline does 
not seem to affect the cell’s response to the excitotoxic insult mediated by NMDA 
exposure for the most part (see Table C-1 and Figure C-2). Resembling the results 
obtained for the DG, significant differences were found between slice cultures exposed to 
2 µM DOM/100 µM NMDA/10 mM choline/10 µM galantamine (74.03% ± 4.43, n=5) 
and OHSCs in the following treatment groups: 2 µM DOM (46.73% ± 4.43, n=7, 
p=0.026), 2 µM DOM/100 µM NMDA/50 mM choline (43.05% ± 2.19, n=8, p=0.010) as 
well as 2 µM DOM/100 µM NMDA/100 mM choline (46.70% ± 3.05, n=8, p=0.016). 
Furthermore, slice cultures exposed to 2 µM DOM/ 100 µM NMDA/ 50 mM choline/ 10 
µM galantamine showed 49.11% ± 4.39 PI uptake (n=5), which approached significance 
when compared to OHSCs in the 2 µM DOM/100 µM NMDA/10 mM choline/10 µM 
galantamine group (p=0.056).  
CA3 
Normality of the data was confirmed using the Kolmogorov-Smirnov test (p>0.05), 
except for the group exposed to 2 µM DOM combined with 50 mM choline (n=7, 
p<0.011). Plotting data from this group in a histogram revealed one outlier. After removal 
of this value, the Kolmogorov-Smirnov test was still significant (p=0.047). However, the 
Shapiro-Wilk test was not significant (p=0.100).  
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Figure C-2: Histograms show quantification of cell damage using propidium iodide (PI) in the hippocampal 
region CA1 of organotypic hippocampal slice cultures. Slice cultures were exposed to different combinations of 
drugs (100 µM NMDA (100N), 2 µM domoic acid (D), 10 mM choline (10C), 50 mM choline (50C) or 100 mM 
choline (100C) and 10 µM galantamine (10G)) for 4 hours. PI uptake was measured after 24 hours in fresh 
media. Data are shown as means ± SEM, with n = 5–9. One way ANOVA using Welch’s correction followed by 
Games-Howell post-hoc test revealed significant differences, *p<0.05 from D + 100N +10C + 10G. 
 
  
* 
* 
* 
p=0.056 
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Levene’s test of homogeneity of variances was not significant for the CA3 hippocampal 
region (p=0.263). A significant difference between groups was found using one way 
ANOVA (F8,52=3.867, p=0.001). Thus, Games-Howell post-hoc tests were performed. 
The general trends seen in the DG and CA1 region were also evident in CA3 (see 
Figure C-3). A low dose of domoic acid alone was able to induce a PI uptake of 23.57% 
± 1.85, which was not significantly altered by administration of 50 mM choline (30.70% 
± 3.43, p=0.671). Furthermore, depolarization by stimulation of non-NMDARs could not 
significantly increase the amount of cell death (34.85% ± 1.73) when compared to 
activation of NMDARs alone (27.62% ± 3.36, p=0.637). As seen in the other 
hippocampal regions, OHSCs exposed to 2 µM DOM/100 µM NMDA/10 mM choline/10 
µM galantamine (41.08% ± 4.45) showed significantly increased PI levels compared to 
slice cultures treated with DOM alone (23.57% ± 1.85, p=0.005) or DOM, NMDA and 
the high dose of choline either alone or in combination with galantamine (26.24% ± 2.30 
and 24.65% ± 1.42, respectively, p=0.022). Additionally, slice cultures exposed to 2 µM 
DOM/100 µM NMDA/10 µM galantamine showed PI uptake of 36.72% ± 3.27, which 
approached significance when compared to OHSCs treated with 2 µM DOM alone 
(p=0.052).  
CONCLUSION 
Compared to administration of 100 µM NMDA alone, addition of a low dose of 
DOM did not significantly increase PI uptake and thus cell death in any of the three 
hippocampal regions, suggesting that blockage of the NMDAR channel pore by Mg
2+
 
ions does not prevent NMDA-mediated excitotoxicity. This further supports the 
conclusions drawn in Chapter 2, suggesting the involvement of glial cell death in the  
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Figure C-3: Histograms show quantification of cell damage using propidium iodide (PI) in the hippocampal 
region CA3 of organotypic hippocampal slice cultures. Slice cultures were exposed to different combination of 
drugs (100 µM NMDA (100N), 2 µM domoic acid (D), 10 mM choline (10C), 50 mM choline (50C) or 100 mM 
choline (100C) and 10 µM galantamine (10G)) for 4 hours. PI uptake was measured after 24 hours in fresh 
media. Data are shown as means ± SEM, with n = 5–9. One way ANOVA followed by Tukey’s post-hoc test 
revealed significant differences, *p<0.05 from D + 100N +10C + 10G. 
 
  
* 
* * 
p=0.052 
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maximal PI uptake measured after exposure to 70% ethanol at 4°C for 24 hours. Thus, 
the cell death of 50% measured after treatment with 1 mM NMDA seems to indicate 
100% neuronal cell damage, as exposure to this concentration of NMDA presumably 
does not affect, or only minimally affects the population of glial cells  
Furthermore, the general observations made in Chapter 3 are supported by these 
data. Despite many reports showing the neuroprotective effect of α7 nicotinic receptors, 
co-activation of α7 nAChR in this experimental setting using choline and/or galantamine 
did not seem to prevent or reduce cell damage. Rather, the highest cell death was 
consistently produced by exposure to 2 µM DOM/100 µM NMDA/10 mM choline/10 
µM galantamine in the DG, CA1, and CA3 region. However, one of the lowest PI levels 
resulted from using either 2 µM DOM/100 µM NMDA/50 mM choline or 2 µM 
DOM/100 µM NMDA/50 mM choline/10 µM galantamine. Both of these groups 
exhibited a similar PI uptake to slice cultures exposed to 2 µM DOM alone.  
The exact reasons for these lower PI levels are unclear. As no significant alterations 
were observed using NMDA alone, these observations suggest the involvement of AMPA 
and kainate receptors. Although interactions between α7 nAChR and AMPA/kainate 
receptors have not received as much attention compared to NMDARs, there are reports 
suggesting that α7 nAChRs can modulate the activity of AMPA and kainate receptors. 
For example, Arias et al (2016) have shown that positive allosteric modulation of α7 
nAChRs weakly potentiates AMPARs. Furthermore, kainic acid-induced neurotoxicity 
was attenuated by activation of α7 nAChRs in rats (Shin et al, 2007).  
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However, it is unclear why a lower concentration of choline (10 mM) produces the 
highest level of PI uptake when combined with 2 µM DOM, 100 µM NMDA, and 10 µM 
galantamine, while administration of 50 mM choline combined with 2 µM DOM, 100 
µM NMDA, and 10 µM galantamine consistently results in one of the lowest levels of PI 
uptake. Further investigations would be necessary to understand the interactions between 
AMPA/kainate receptors and α7 nAChRs.  
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APPENDIX D: IMMUNOHISTOCHEMICAL STAINING WITH NEURONAL 
AND ASTROCYTIC MARKERS 
 
OBJECTIVE 
In our experiments, PI uptake following exposure to NMDA seemed to plateau at 
about 50% of the maximal PI uptake (see Chapter 2). This observation is similar to 
results published by Kleczkowska et al (2015), whereas other publications suggest higher 
values of PI uptake (Kristensen et al, 2001). As described in Chapter 2, a possible 
explanation for these differences in the literature could be variations in experimental 
procedures, such as differences in exposure timing or culture media used. The method 
chosen to induce maximal cell death, as a way of standardizing the data, can also likely 
influence the measured PI uptake. For example, Kristensen et al (2001) exposed OHSCs 
to 50 mM Glu following drug treatment to obtain the maximum value of PI uptake, while 
maximal fluorescence intensity in the experiments described in this thesis was measured 
after 24 h low-temperature exposure to 70% ethanol. Kleczkowska et al (2015) chose yet 
another method and acquired terminal images after treatment with supramaximal 
concentrations of NMDA.  
Organotypic slice cultures consist of both neuronal cells and glial cells. Glial cells 
have been shown to generally be more resistant to ischemic cell death (Goldberg and 
Choi, 1993). However, they are susceptible to cell death induced by ethanol or extremely 
high doses of NMDA (Holownia et al, 1997). This might explain the discrepancy in 
reported PI uptake after NMDA exposure if the measure of 100% cell death is based on 
neurons and glia combined vs neurons alone. 
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To investigate whether glial cell death is in fact implicated in the maximal PI uptake 
as reported in this thesis, slice cultures were stained with antibodies against NeuN, a 
neuron specific nuclear protein, and GFAP, a commonly used marker for astrocytes, to 
differentiate neuronal and glial populations in OHSCs.  
METHODS 
Preparation of organotypic hippocampal slice cultures, maintenance, and exposure 
procedures were as reported in Chapter 2 and Chapter 3 of this thesis. On day 13 in vitro, 
three representative OHSCs (on the same dish) were prepared for formalin fixation 
without any treatment. Immunohistochemical protocols were adapted from methods 
previously published by our laboratory (Pérez-Gómez and Tasker, 2012, 2013). After 
washing 3 times with 1x PBS at room temperature, the same process was repeated using 
10% neutral buffered formalin. Extra formalin was added after the third wash to the top 
of the insert covering the slices. The slices were then left in the final formalin wash for 5 
hours at 4°C. The slices were then washed again with 1x PBS, transferred to ethylene 
glycol solution and stored at -20°C. 
Slices to be labelled were rinsed in two washes of 1x PBS for 3 minutes each to 
remove ethylene glycol solution. Slices were then placed in permeabilization buffer (1× 
PBS + 0.1% Triton X solution) overnight at 4°C, followed by incubation with blocking 
solution (20% BSA in 1x PBS + 0.1% Triton X) for 6 h at room temperature. They were 
then incubated with mouse anti-NeuN (1:500, Millipore) and rabbit anti-GFAP (1:500, 
Sigma) diluted in 5% goat serum in 1x PBS + 0.1% Triton X overnight at 4°C. Following 
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incubation with primary antibody, sections were washed in 1x PBS (3 x 10 minutes), and 
incubated with secondary antibody (1:200, Alexa Fluor 594-conjugated goat anti-mouse 
and 488-conjugated chicken anti-rabbit, Thermo Fisher Scientific) diluted in PBS 
containing 5% BSA for 4 h in the dark at room temperature. The sections were 
subsequently washed in PBS (3 × 10 minutes) in the dark, mounted on microscope slides 
in mounting medium (Thermo Fisher Scientific) and imaged using a LSM 710 laser 
scanning confocal microscope (Zeiss, Germany). 
RESULTS 
Figure D-1 shows a representative image of a slice culture double-labelled with the 
neuronal marker NeuN and the astrocytic marker GFAP.  
CONCLUSION 
The results suggest that approximately 50% of the cells in OHSC label with the 
neuronal marker NeuN, whereas the other 50% label with GFAP. In our experiments, 
after exposure to 1 mM NMDA about 50% cell death was measured (Figure 2-2), and 
most likely this value reflects 100% neuronal damage.  
The ratio of neuronal and glial cells seems to vary, however, between hippocampal 
sub-fields possibly contributing to regional differences, although further studies to 
confirm this hypothesis are necessary. 
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Figure D-1: Confocal images showing double staining for NeuN and GFAP in formalin fixed organotypic 
hippocampal slice culture at day 13 in vitro. (A) Representative image of whole slice with the blue boxes 
indicating location of magnified images for CA3 (B), CA1 (C), and dentate gyrus (D). 
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